1834780
1
nature
50
default
17
https://sites.duke.edu/palmerlab/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A250%2C%22request_next%22%3A50%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22WC8QNSXE%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Banks%20et%20al.%22%2C%22parsedDate%22%3A%222013-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBanks%2C%20P.%20A.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20Classification%20of%20acute%20pancreatitis--2012%3A%20revision%20of%20the%20Atlanta%20classification%20and%20definitions%20by%20international%20consensus.%20%3Ci%3EGut%3C%5C%2Fi%3E%20%3Cb%3E62%3C%5C%2Fb%3E%2C%20102%26%23x2013%3B111%20%282013%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Classification%20of%20acute%20pancreatitis--2012%3A%20revision%20of%20the%20Atlanta%20classification%20and%20definitions%20by%20international%20consensus%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20A.%22%2C%22lastName%22%3A%22Banks%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20L.%22%2C%22lastName%22%3A%22Bollen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christos%22%2C%22lastName%22%3A%22Dervenis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hein%20G.%22%2C%22lastName%22%3A%22Gooszen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Colin%20D.%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20G.%22%2C%22lastName%22%3A%22Sarr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%20G.%22%2C%22lastName%22%3A%22Tsiotos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Santhi%20Swaroop%22%2C%22lastName%22%3A%22Vege%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Acute%20Pancreatitis%20Classification%20Working%20Group%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%20AND%20OBJECTIVE%3A%20The%20Atlanta%20classification%20of%20acute%20pancreatitis%20enabled%20standardised%20reporting%20of%20research%20and%20aided%20communication%20between%20clinicians.%20Deficiencies%20identified%20and%20improved%20understanding%20of%20the%20disease%20make%20a%20revision%20necessary.%5CnMETHODS%3A%20A%20web-based%20consultation%20was%20undertaken%20in%202007%20to%20ensure%20wide%20participation%20of%20pancreatologists.%20After%20an%20initial%20meeting%2C%20the%20Working%20Group%20sent%20a%20draft%20document%20to%2011%20national%20and%20international%20pancreatic%20associations.%20This%20working%20draft%20was%20forwarded%20to%20all%20members.%20Revisions%20were%20made%20in%20response%20to%20comments%2C%20and%20the%20web-based%20consultation%20was%20repeated%20three%20times.%20The%20final%20consensus%20was%20reviewed%2C%20and%20only%20statements%20based%20on%20published%20evidence%20were%20retained.%5CnRESULTS%3A%20The%20revised%20classification%20of%20acute%20pancreatitis%20identified%20two%20phases%20of%20the%20disease%3A%20early%20and%20late.%20Severity%20is%20classified%20as%20mild%2C%20moderate%20or%20severe.%20Mild%20acute%20pancreatitis%2C%20the%20most%20common%20form%2C%20has%20no%20organ%20failure%2C%20local%20or%20systemic%20complications%20and%20usually%20resolves%20in%20the%20first%20week.%20Moderately%20severe%20acute%20pancreatitis%20is%20defined%20by%20the%20presence%20of%20transient%20organ%20failure%2C%20local%20complications%20or%20exacerbation%20of%20co-morbid%20disease.%20Severe%20acute%20pancreatitis%20is%20defined%20by%20persistent%20organ%20failure%2C%20that%20is%2C%20organ%20failure%20%3E48%20h.%20Local%20complications%20are%20peripancreatic%20fluid%20collections%2C%20pancreatic%20and%20peripancreatic%20necrosis%20%28sterile%20or%20infected%29%2C%20pseudocyst%20and%20walled-off%20necrosis%20%28sterile%20or%20infected%29.%20We%20present%20a%20standardised%20template%20for%20reporting%20CT%20images.%5CnCONCLUSIONS%3A%20This%20international%2C%20web-based%20consensus%20provides%20clear%20definitions%20to%20classify%20acute%20pancreatitis%20using%20easily%20identified%20clinical%20and%20radiologic%20criteria.%20The%20wide%20consultation%20among%20pancreatologists%20to%20reach%20this%20consensus%20should%20encourage%20widespread%20adoption.%22%2C%22date%22%3A%22Jan%202013%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1136%5C%2Fgutjnl-2012-302779%22%2C%22ISSN%22%3A%221468-3288%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222020-01-04T02%3A51%3A26Z%22%7D%7D%2C%7B%22key%22%3A%2266AVVHZK%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Malecki%20et%20al.%22%2C%22parsedDate%22%3A%222014-08%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMalecki%2C%20E.%20A.%2C%20Castellanos%2C%20K.%20J.%2C%20Cabay%2C%20R.%20J.%20%26amp%3B%20Fantuzzi%2C%20G.%20Therapeutic%20administration%20of%20orlistat%2C%20rosiglitazone%20or%20the%20chemokine%20receptor%20antagonist%20RS102895%20fails%20to%20improve%20the%20severity%20of%20acute%20pancreatitis%20in%20obese%20mice.%20%3Ci%3EPancreas%3C%5C%2Fi%3E%20%3Cb%3E43%3C%5C%2Fb%3E%2C%20903%26%23x2013%3B908%20%282014%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Therapeutic%20administration%20of%20orlistat%2C%20rosiglitazone%20or%20the%20chemokine%20receptor%20antagonist%20RS102895%20fails%20to%20improve%20the%20severity%20of%20acute%20pancreatitis%20in%20obese%20mice%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elise%20A.%22%2C%22lastName%22%3A%22Malecki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karla%20J.%22%2C%22lastName%22%3A%22Castellanos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20J.%22%2C%22lastName%22%3A%22Cabay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giamila%22%2C%22lastName%22%3A%22Fantuzzi%22%7D%5D%2C%22abstractNote%22%3A%22Objectives%5CnCurrently%20there%20is%20no%20therapy%20for%20severe%20acute%20pancreatitis%20except%20for%20supportive%20care.%20The%20lipase%20inhibitor%20orlistat%2C%20the%20peroxisome%20proliferator-activated%20receptor-gamma%20agonist%20rosiglitazone%2C%20and%20chemokine%20receptor-2%20antagonists%20attenuate%20the%20severity%20of%20acute%20pancreatitis%20in%20rodents%20if%20administered%20prior%20to%20or%20at%20the%20time%20of%20induction%20of%20pancreatitis.%20However%2C%20it%20is%20unknown%20whether%20these%20treatments%20are%20effective%20if%20administered%20therapeutically%20after%20induction%20of%20pancreatitis.%5Cn%5CnMethods%5CnMale%20C57BL6%20mice%20with%20diet-induced%20obesity%20received%20two%20injections%20of%20mrIL-12%20%28150%20ng%5C%2Fmouse%29%20and%20mrIL-18%20%28750%20ng%5C%2Fmouse%29%20intraperitoneally%20at%2024%20h%20intervals.%20Mice%20were%20injected%202%2C%2024%2C%20and%2048%20hours%20after%20the%20second%20injection%20of%20IL-12%2BIL-18%20with%20orlistat%20%282%20mg%5C%2Fmouse%29%2C%20rosiglitazone%20%280.4%20mg%5C%2Fmouse%29%2C%20RS102895%20%280.3%20mg%5C%2Fmouse%29%2C%20or%20vehicle%20%2820%5Cu03bcL%20DMSO%20and%2080%20%5Cu03bcL%20canola%20oil%29%20and%20euthanized%20after%2072%20hours.%5Cn%5CnResults%5CnOrlistat%20decreased%20intraabdominal%20fat%20necrosis%20compared%20to%20vehicle%20%28p%3C0.05%29.%20However%2C%20none%20of%20the%20drug%20treatments%20produced%20significant%20decreases%20in%20pancreatic%20edema%2C%20acinar%20necrosis%2C%20or%20intrapancreatic%20fat%20necrosis.%5Cn%5CnConclusions%5CnDrugs%20previously%20shown%20to%20improve%20the%20severity%20of%20acute%20pancreatitis%20when%20given%20prior%20to%20or%20at%20the%20time%20of%20induction%20of%20pancreatitis%2C%20failed%20to%20do%20so%20when%20administered%20therapeutically%20in%20the%20IL-12%2BIL-18%20model.%22%2C%22date%22%3A%222014-8%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1097%5C%2FMPA.0000000000000115%22%2C%22ISSN%22%3A%220885-3177%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4151050%5C%2F%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222020-01-04T02%3A34%3A35Z%22%7D%7D%2C%7B%22key%22%3A%22VF3DESAM%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lilja%20et%20al.%22%2C%22parsedDate%22%3A%222008-03-08%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELilja%2C%20H.%20E.%2C%20Lepp%26%23xE4%3Bniemi%2C%20A.%20%26amp%3B%20Kemppainen%2C%20E.%20Utilization%20of%20intensive%20care%20unit%20resources%20in%20severe%20acute%20pancreatitis.%20%3Ci%3EJOP%3C%5C%2Fi%3E%20%3Cb%3E9%3C%5C%2Fb%3E%2C%20179%26%23x2013%3B184%20%282008%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Utilization%20of%20intensive%20care%20unit%20resources%20in%20severe%20acute%20pancreatitis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heidi%20E.%22%2C%22lastName%22%3A%22Lilja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ari%22%2C%22lastName%22%3A%22Lepp%5Cu00e4niemi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Esko%22%2C%22lastName%22%3A%22Kemppainen%22%7D%5D%2C%22abstractNote%22%3A%22CONTEXT%3A%20Severe%20acute%20pancreatitis%20is%20a%20common%20abdominal%20emergency%3B%20it%20is%20a%20potentially%20fulminant%20disease%20with%20no%20specific%20treatment.%20The%20incidence%20of%20severe%20acute%20pancreatitis%20is%20increasing%2C%20but%20the%20overall%20population%20mortality%20rate%20has%20remained%20unchanged%20as%20the%20case%20fatality%20rate%20has%20decreased%20over%20time.%20The%20hospital%20mortality%20rate%20of%20patients%20with%20severe%20acute%20pancreatitis%20has%20dropped%20to%2020%25%20even%20in%20the%20most%20severe%20forms%20of%20the%20disease.%20The%20prolonged%20course%20of%20severe%20acute%20pancreatitis%2C%20associated%20with%20multi-organ%20failure%20and%20other%20complications%2C%20is%20a%20considerable%20strain%20on%20intensive%20care%20unit%20%28ICU%29%20resources.%5CnOBJECTIVE%3A%20To%20analyze%20the%20extent%20of%20ICU%20resources%20consumed%20by%20the%20severe%20acute%20pancreatitis%20patient%20group%20as%20well%20as%20the%20expenses%20of%20the%20treatment%20and%20differences%20in%20the%20costs%20of%20survivors%20versus%20patients%20who%20die%20after%20a%20prolonged%20stay%20in%20the%20ICU.%5CnDESIGN%3A%20Retrospective%20study.%5CnPARTICIPANTS%3A%20All%20patients%20with%20severe%20acute%20pancreatitis%20treated%20in%20the%20general%20ICU%20of%20Helsinki%20University%20Hospital%20from%201995%20to%202005%20%28245%20patients%3B%20169%20%2869.0%25%29%20with%20alcohol-induced%20severe%20acute%20pancreatitis%29.%5CnRESULTS%3A%20The%20mean%20length%20of%20the%20ICU%20stay%20was%2017.4%20days%20and%20severe%20acute%20pancreatitis%20patients%20constituted%2017.0%25%20of%20all%20ICU%20days.%20The%20mean%20hospital%20cost%20per%20patient%20was%2086%2C856%20Euros.%20The%20overall%20mortality%20rate%20was%2026.1%25%20and%20the%20hospital%20costs%20of%20the%20non-survivors%20seemed%20to%20be%20higher%20%28although%20not%20significantly%29%20than%20that%20of%20the%20survivors.%5CnCONCLUSIONS%3A%20Optimal%20early%20care%20in%20order%20to%20decrease%20the%20onset%20of%20organ%20dysfunctions%20and%20better%20prognostic%20models%20to%20identify%20non-surviving%20severe%20acute%20pancreatitis%20patients%20earlier%20could%20lead%20to%20considerable%20savings%20in%20the%20overall%20use%20of%20ICU%20resources.%22%2C%22date%22%3A%22Mar%2008%2C%202008%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%221590-8577%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-09-02T20%3A32%3A24Z%22%7D%7D%2C%7B%22key%22%3A%22TNEVEKRN%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Buter%20et%20al.%22%2C%22parsedDate%22%3A%222002-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EButer%2C%20A.%2C%20Imrie%2C%20C.%20W.%2C%20Carter%2C%20C.%20R.%2C%20Evans%2C%20S.%20%26amp%3B%20McKay%2C%20C.%20J.%20Dynamic%20nature%20of%20early%20organ%20dysfunction%20determines%20outcome%20in%20acute%20pancreatitis.%20%3Ci%3EBr%20J%20Surg%3C%5C%2Fi%3E%20%3Cb%3E89%3C%5C%2Fb%3E%2C%20298%26%23x2013%3B302%20%282002%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Dynamic%20nature%20of%20early%20organ%20dysfunction%20determines%20outcome%20in%20acute%20pancreatitis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Buter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20W.%22%2C%22lastName%22%3A%22Imrie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20R.%22%2C%22lastName%22%3A%22Carter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Evans%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20J.%22%2C%22lastName%22%3A%22McKay%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20All%20patients%20with%20organ%20dysfunction%20are%20currently%20classified%20as%20having%20severe%20acute%20pancreatitis.%20The%20aim%20of%20this%20study%20was%20to%20characterize%20the%20systemic%20inflammatory%20response%20syndrome%20%28SIRS%29%20and%20early%20organ%20dysfunction%20in%20patients%20with%20acute%20pancreatitis%20and%20the%20relationship%20with%20overall%20mortality.%5CnMETHODS%3A%20Patients%20with%20predicted%20severe%20acute%20pancreatitis%20of%20less%20than%2048%20h%20duration%20had%20daily%20organ%20dysfunction%20scores%20and%20SIRS%20criteria%20calculated.%20These%20features%20were%20then%20correlated%20with%20outcome.%5CnRESULTS%3A%20Of%20121%20patients%2C%2068%20%2856%20per%20cent%29%20did%20not%20develop%20organ%20dysfunction%3B%20only%20two%20of%20these%20patients%20died%20%28mortality%20rate%203%20per%20cent%29.%20Fifty-three%20%2844%20per%20cent%29%20had%20early%20organ%20dysfunction%2C%20of%20whom%2011%20died%20%2821%20per%20cent%29.%20Organ%20dysfunction%20and%20persistent%20SIRS%20were%20both%20associated%20with%20an%20increased%20mortality%20rate%2C%20but%20on%20multivariate%20analysis%20only%20deteriorating%20organ%20dysfunction%20was%20an%20independent%20determinant%20of%20survival.%5CnCONCLUSION%3A%20Early%20organ%20dysfunction%20in%20acute%20pancreatitis%20usually%20resolves%20and%20in%20itself%20has%20no%20significant%20influence%20on%20mortality.%20In%20contrast%2C%20worsening%20organ%20dysfunction%20was%20associated%20with%20death%20in%20more%20than%20half%20of%20the%20patients%20%2811%20of%2020%29%3B%20it%20is%20this%20group%20of%20patients%20who%20should%20be%20classified%20as%20having%20severe%20acute%20pancreatitis.%22%2C%22date%22%3A%22Mar%202002%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1046%5C%2Fj.0007-1323.2001.02025.x%22%2C%22ISSN%22%3A%220007-1323%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-09-02T20%3A31%3A08Z%22%7D%7D%2C%7B%22key%22%3A%228U7GJ68T%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mofidi%20et%20al.%22%2C%22parsedDate%22%3A%222006-06%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMofidi%2C%20R.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20Association%20between%20early%20systemic%20inflammatory%20response%2C%20severity%20of%20multiorgan%20dysfunction%20and%20death%20in%20acute%20pancreatitis.%20%3Ci%3EBr%20J%20Surg%3C%5C%2Fi%3E%20%3Cb%3E93%3C%5C%2Fb%3E%2C%20738%26%23x2013%3B744%20%282006%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Association%20between%20early%20systemic%20inflammatory%20response%2C%20severity%20of%20multiorgan%20dysfunction%20and%20death%20in%20acute%20pancreatitis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Mofidi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20D.%22%2C%22lastName%22%3A%22Duff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20J.%22%2C%22lastName%22%3A%22Wigmore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20K.%22%2C%22lastName%22%3A%22Madhavan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%20J.%22%2C%22lastName%22%3A%22Garden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20W.%22%2C%22lastName%22%3A%22Parks%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Mortality%20in%20patients%20with%20acute%20pancreatitis%20is%20associated%20with%20the%20number%20of%20failing%20organs%20and%20the%20severity%20and%20reversibility%20of%20organ%20dysfunction.%20The%20aim%20of%20this%20study%20was%20to%20assess%20the%20significance%20of%20early%20systemic%20inflammatory%20response%20syndrome%20%28SIRS%29%20in%20the%20development%20of%20multiorgan%20dysfunction%20syndrome%20%28MODS%29%20and%20death%20from%20acute%20pancreatitis.%5CnMETHODS%3A%20Data%20for%20all%20patients%20with%20a%20diagnosis%20of%20acute%20pancreatitis%20between%20January%202000%20and%20December%202004%20were%20reviewed.%20Serum%20C-reactive%20protein%20%28CRP%29%2C%20Acute%20Physiology%20And%20Chronic%20Health%20Evaluation%20%28APACHE%29%20II%20scores%20and%20presence%20of%20SIRS%20were%20recorded%20on%20admission%20and%20at%2048%20h.%20Marshall%20organ%20dysfunction%20scores%20were%20calculated%20during%20the%20first%20week%20of%20presentation.%20Presence%20of%20SIRS%20and%20raised%20serum%20CRP%20levels%20on%20admission%20and%20at%2048%20h%20were%20correlated%20with%20the%20cumulative%20organ%20dysfunction%20scores%20in%20the%20first%20week.%5CnRESULTS%3A%20A%20total%20of%20759%20patients%20with%20acute%20pancreatitis%20were%20identified%2C%20of%20whom%2045%20%285.9%20per%20cent%29%20died%20during%20the%20index%20admission.%20SIRS%20was%20identified%20in%20162%20patients%20on%20admission%20and%20was%20persistent%20in%20138%20at%2048%20h.%20The%20median%20%28range%29%20cumulative%20Marshall%20score%20in%20patients%20with%20persistent%20SIRS%20was%20significantly%20higher%20than%20that%20in%20patients%20in%20whom%20SIRS%20resolved%20and%20in%20those%20with%20no%20SIRS%20%284%20%280-12%29%2C%203%20%280-7%29%20and%200%20%280-9%29%20respectively%3B%20P%20%3C%200.001%29.%20Thirty-five%20patients%20%2825.4%20per%20cent%29%20with%20persistent%20SIRS%20died%20from%20acute%20pancreatitis%2C%20compared%20with%20six%20patients%20%288%20per%20cent%29%20with%20transient%20SIRS%20and%20four%20%280.7%20per%20cent%29%20without%20SIRS%20%28P%20%3C%200.001%29.%20No%20correlation%20was%20observed%20between%20CRP%20level%20on%20admission%20and%20Marshall%20score%20%28P%20%3D%200.810%29%3B%20however%2C%20there%20was%20a%20close%20correlation%20between%20CRP%20level%20at%2048%20h%20and%20Marshall%20score%20%28P%20%3C%200.001%29.%5CnCONCLUSION%3A%20Persistent%20SIRS%20is%20associated%20with%20MODS%20and%20death%20in%20patients%20with%20acute%20pancreatitis%20and%20is%20an%20early%20indicator%20of%20the%20likely%20severity%20of%20acute%20pancreatitis.%22%2C%22date%22%3A%22Jun%202006%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fbjs.5290%22%2C%22ISSN%22%3A%220007-1323%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-09-02T20%3A29%3A52Z%22%7D%7D%2C%7B%22key%22%3A%22P2MFQ39T%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Singh%20et%20al.%22%2C%22parsedDate%22%3A%222017-12%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESingh%2C%20H.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20Which%20Patients%20with%20Mild%20Acute%20Pancreatitis%20Require%20Prolonged%20Hospitalization%3F%20%3Ci%3EClin%20Transl%20Gastroenterol%3C%5C%2Fi%3E%20%3Cb%3E8%3C%5C%2Fb%3E%2C%20e129%20%282017%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Which%20Patients%20with%20Mild%20Acute%20Pancreatitis%20Require%20Prolonged%20Hospitalization%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harkirat%22%2C%22lastName%22%3A%22Singh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amir%22%2C%22lastName%22%3A%22Gougol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rawad%22%2C%22lastName%22%3A%22Mounzer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dhiraj%22%2C%22lastName%22%3A%22Yadav%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Efstratios%22%2C%22lastName%22%3A%22Koutroumpakis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%22%2C%22lastName%22%3A%22Slivka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20C%22%2C%22lastName%22%3A%22Whitcomb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Georgios%20I%22%2C%22lastName%22%3A%22Papachristou%22%7D%5D%2C%22abstractNote%22%3A%22Objectives%3A%5CnIn%20our%20experience%2C%20a%20subset%20of%20mild%20acute%20pancreatitis%20%28AP%29%20patients%2C%20as%20defined%20by%20the%20Revised%20Atlanta%20Classification%2C%20has%20longer%20than%20expected%20hospitalization.%20Our%20aims%20are%20to%20report%20the%20prevalence%20of%20patients%20with%20mild%20AP%20who%20have%20a%20prolonged%20length%20of%20stay%20%28LOS%29%2C%20evaluate%20the%20etiology%2C%20thoroughly%20phenotype%2C%20and%20finally%20compare%20this%20subset%20to%20those%20with%20expected%20LOS.%5Cn%5CnMethods%3A%5CnPatients%20admitted%20with%20AP%20from%202003%20to%202015%20were%20prospectively%20enrolled%20into%20this%20cohort%20study.%20LOS%20%5Cu22658%20days%20was%20considered%20as%20prolonged%20LOS.%20Data%20on%20demographics%2C%20clinical%20and%20laboratory%20variables%2C%20management%2C%20and%20outcomes%20was%20both%20prospectively%20and%20retrospectively%20collected.%20Continuous%20variables%20were%20compared%20using%20the%20nonparametric%20t-test%20%28Wilcoxon%27s%20test%29%20and%20categorical%20variables%20using%20the%20Pearson%5Cu2019s%20%5Cu03c72%20test.%5Cn%5CnResults%3A%5CnAmong%20231%20enrolled%20mild%20AP%20patients%2C%2046%20%2820%25%29%20had%20a%20prolonged%20LOS%20%28%5Cu22658%20days%29.%20The%20main%20determinants%20of%20prolonged%20LOS%20included%20ongoing%20pancreatitis-related%20symptoms%20%28n%3D31%2C%2067.4%25%29%20and%20performance%20of%20cholecystectomy%20%28n%3D11%2C%2023.9%25%29.%20When%20compared%20to%20patients%20with%20expected%20LOS%20%28%3C8%20days%2C%20n%3D185%29%2C%20patients%20with%20prolonged%20LOS%20due%20to%20ongoing%20symptoms%20%28n%3D31%29%20were%20more%20likely%20to%20have%20systemic%20inflammatory%20response%20syndrome%20at%2048%5Cu2009h%20from%20admission%20%2837%25%20vs.%2013.4%25%2C%20P%3C0.001%29%2C%20a%20prolonged%20fasting%20period%20%286.6%20vs.%202.8%20days%2C%20P%3C0.001%29%2C%20and%20need%20for%20nutritional%20support%20%2830%25%20vs.%201.6%25%2C%20P%3C0.001%29.%5Cn%5CnConclusions%3A%5CnAbout%2020%25%20of%20patients%20with%20mild%20AP%20have%20a%20longer%20than%20expected%20hospital%20stay%2C%20mostly%20attributed%20to%20ongoing%20pancreatitis-related%20symptoms.%20An%20early%20decision%20%28at%2072%5Cu2009h%29%20for%20enteral%20nutrition%20support%20in%20these%20patients%20needs%20to%20be%20explored%20so%20as%20to%20shorten%20hospitalization%20and%20reduce%20cost%20of%20care.%22%2C%22date%22%3A%222017-12%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1038%5C%2Fctg.2017.55%22%2C%22ISSN%22%3A%222155-384X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5746601%5C%2F%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-09-02T03%3A33%3A58Z%22%7D%7D%2C%7B%22key%22%3A%22E9IQZWUY%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kroner%20et%20al.%22%2C%22parsedDate%22%3A%222017-04-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EKroner%2C%20P.%20T.%2C%20Jirapinyo%2C%20P.%2C%20Abougergi%2C%20M.%20S.%20%26amp%3B%20Thompson%2C%20C.%20C.%20Acute%20Pancreatitis%20Regional%20and%20Divisional%20Cost%20Variations%20Throughout%20the%20United%20States%3A%20A%2010-Year%20Nationwide%20analysis.%20%3Ci%3EGastroenterology%3C%5C%2Fi%3E%20%3Cb%3E152%3C%5C%2Fb%3E%2C%20S445%20%282017%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Acute%20Pancreatitis%20Regional%20and%20Divisional%20Cost%20Variations%20Throughout%20the%20United%20States%3A%20A%2010-Year%20Nationwide%20analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20T.%22%2C%22lastName%22%3A%22Kroner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pichamol%22%2C%22lastName%22%3A%22Jirapinyo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marwan%20S.%22%2C%22lastName%22%3A%22Abougergi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20C.%22%2C%22lastName%22%3A%22Thompson%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222017%5C%2F04%5C%2F01%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1016%5C%2FS0016-5085%2817%2931697-9%22%2C%22ISSN%22%3A%220016-5085%2C%201528-0012%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.gastrojournal.org%5C%2Farticle%5C%2FS0016-5085%2817%2931697-9%5C%2Fabstract%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-09-02T03%3A31%3A22Z%22%7D%7D%2C%7B%22key%22%3A%22UCVM8BSC%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Andersson%20et%20al.%22%2C%22parsedDate%22%3A%222013-12-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAndersson%2C%20B.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20Acute%20pancreatitis%20%26%23x2013%3B%20costs%20for%20healthcare%20and%20loss%20of%20production.%20%3Ci%3EScandinavian%20Journal%20of%20Gastroenterology%3C%5C%2Fi%3E%20%3Cb%3E48%3C%5C%2Fb%3E%2C%201459%26%23x2013%3B1465%20%282013%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Acute%20pancreatitis%20%5Cu2013%20costs%20for%20healthcare%20and%20loss%20of%20production%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bodil%22%2C%22lastName%22%3A%22Andersson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bj%5Cu00f6rn%22%2C%22lastName%22%3A%22Appelgren%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Viktor%22%2C%22lastName%22%3A%22Sj%5Cu00f6din%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Ansari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johan%22%2C%22lastName%22%3A%22Nilsson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ulf%22%2C%22lastName%22%3A%22Persson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bobby%22%2C%22lastName%22%3A%22Tingstedt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roland%22%2C%22lastName%22%3A%22Andersson%22%7D%5D%2C%22abstractNote%22%3A%22Objective.%20Severity%20of%20acute%20pancreatitis%20%28AP%29%20can%20vary%20from%20a%20mild%20to%20a%20fulminant%20disease%20with%20high%20morbidity%20and%20mortality.%20Cost%20analysis%20has%2C%20however%2C%20hitherto%20been%20sparse.%20The%20aim%20of%20this%20study%20was%20to%20calculate%20the%20cost%20of%20acute%20pancreatitis%2C%20both%20including%20hospital%20costs%20and%20costs%20due%20to%20loss%20of%20production.%20Material%20and%20methods.%20All%20adult%20patients%20treated%20at%20Skane%20University%20Hospital%2C%20Lund%2C%20during%202009%5Cu20132010%2C%20were%20included.%20A%20severity%20grading%20was%20conducted%20and%20cost%20analysis%20was%20performed%20on%20an%20individual%20basis.%20Results.%20Two%20hundred%20and%20fifty-two%20patients%20with%20altogether%20307%20admissions%20were%20identified.%20Mean%20age%20was%2060%20%5Cu00b1%2019%20years%2C%20and%20121%20patients%20%2848%25%29%20were%20men.%20Severe%20AP%20%28SAP%29%20was%20diagnosed%20in%2038%20patients%20%2812%25%29.%20Thirteen%20patients%20%285%25%29%20died.%20Acute%20biliary%20pancreatitis%20was%20more%20costly%20than%20alcohol%20induced%20AP%20%28p%20%3C%200.001%29.%20Total%20costs%20for%20treating%20mild%20AP%20%28MAP%29%20in%20patients%20%5Cu226465%20years%20old%20was%20lower%20%28p%20%3D%200.001%29%20and%20costs%20for%20SAP%20was%20higher%20%28p%20%3D%200.024%29%2C%20as%20compared%20to%20older%20patients.%20The%20overall%20hospital%20cost%20and%20cost%20for%20loss%20of%20production%20was%20per%20person%20in%20mean%20%5Cu20ac5%2C100%20%5Cu00b1%202%2C400%20for%20MAP%20and%20%5Cu20ac28%2C200%20%5Cu00b1%2038%2C100%20for%20SAP%20%28p%20%3C%200.001%29.%20The%20costs%20for%20treating%20AP%20during%20the%20two-year-long%20study%20period%20were%20in%20mean%20%5Cu20ac9%2C762%20%5Cu00b1%2019%2C778%20per%20patient.%20Extrapolated%20to%20a%20national%20perspective%2C%20the%20annual%20financial%20burden%20for%20AP%20in%20Sweden%20would%20be%20%5Cu223c%20%5Cu20ac38%2C500%2C000%3B%20corresponding%20to%20%5Cu20ac4%2C100%2C000%20per%20million%20inhabitants.%20Conclusions.%20The%20costs%20of%20treating%20AP%20are%20high%2C%20especially%20in%20severe%20cases%20with%20a%20long%20ICU%20stay.%20These%20results%20highlight%20the%20need%20to%20optimize%20care%20and%20continue%20the%20identification%20and%20focus%20on%20SAP%2C%20in%20order%20to%20try%20to%20limit%20organ%20failure%20and%20infectious%20complications.%22%2C%22date%22%3A%22December%201%2C%202013%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.3109%5C%2F00365521.2013.843201%22%2C%22ISSN%22%3A%220036-5521%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3109%5C%2F00365521.2013.843201%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-09-02T03%3A29%3A48Z%22%7D%7D%2C%7B%22key%22%3A%22LYQCIWNW%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rashid%20et%20al.%22%2C%22parsedDate%22%3A%222015-05-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERashid%2C%20N.%2C%20Sharma%2C%20P.%2C%20Scott%2C%20R.%20%26amp%3B%20Toth%2C%20P.%20Evaluation%20of%20Healthcare%20Care%20Utilization%20and%20Costs%20Related%20to%20Acute%20Pancreatitis%20for%20Patients%20with%20Very%20Severe%20Hypertriglyceridemia.%20%3Ci%3EJournal%20of%20Clinical%20Lipidology%3C%5C%2Fi%3E%20%3Cb%3E9%3C%5C%2Fb%3E%2C%20431%26%23x2013%3B432%20%282015%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Evaluation%20of%20Healthcare%20Care%20Utilization%20and%20Costs%20Related%20to%20Acute%20Pancreatitis%20for%20Patients%20with%20Very%20Severe%20Hypertriglyceridemia%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nazia%22%2C%22lastName%22%3A%22Rashid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Puza%22%2C%22lastName%22%3A%22Sharma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ronald%22%2C%22lastName%22%3A%22Scott%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Toth%22%7D%5D%2C%22abstractNote%22%3A%22This%20study%20was%20funded%20by%20Novartis%20Pharmaceuticals%20Corp.%20through%20a%20investigator%20initiated%5Cngrant.%22%2C%22date%22%3A%222015%5C%2F05%5C%2F01%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jacl.2015.03.040%22%2C%22ISSN%22%3A%221933-2874%2C%201876-4789%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.lipidjournal.com%5C%2Farticle%5C%2FS1933-2874%2815%2900127-0%5C%2Fabstract%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-09-02T03%3A28%3A42Z%22%7D%7D%2C%7B%22key%22%3A%22A7CR996A%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Beenen%20et%20al.%22%2C%22parsedDate%22%3A%222011-03-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBeenen%2C%20E.%2C%20Brown%2C%20L.%20%26amp%3B%20Connor%2C%20S.%20A%20comparison%20of%20the%20hospital%20costs%20of%20open%20vs.%20minimally%20invasive%20surgical%20management%20of%20necrotizing%20pancreatitis.%20%3Ci%3EHPB%3C%5C%2Fi%3E%20%3Cb%3E13%3C%5C%2Fb%3E%2C%20178%26%23x2013%3B184%20%282011%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20comparison%20of%20the%20hospital%20costs%20of%20open%20vs.%20minimally%20invasive%20surgical%20management%20of%20necrotizing%20pancreatitis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edwin%22%2C%22lastName%22%3A%22Beenen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lisa%22%2C%22lastName%22%3A%22Brown%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Saxon%22%2C%22lastName%22%3A%22Connor%22%7D%5D%2C%22abstractNote%22%3A%22Background%5CnInfected%20necrotizing%20pancreatitis%20is%20a%20major%20burden%20for%20both%20the%20patient%20and%20the%20health%20care%20system.%20Little%20is%20known%20about%20how%20hospital%20costs%20break%20down%20and%20how%20they%20may%20have%20shifted%20with%20the%20increasing%20use%20of%20minimally%20invasive%20techniques.%20The%20aim%20of%20this%20study%20was%20to%20analyse%20inpatient%20hospital%20costs%20associated%20with%20pancreatic%20necrosectomy.%5CnMethods%5CnA%20prospective%20database%20was%20used%20to%20identify%20all%20patients%20who%20underwent%20an%20intervention%20for%20necrotizing%20pancreatitis.%20Costs%20of%20treatment%20were%20calculated%20using%20detailed%20information%20from%20the%20Decision%20Support%20Department.%20Costs%20for%20open%20and%20minimally%20invasive%20surgical%20modalities%20were%20compared.%5CnResults%5CnTwelve%20open%20and%2013%20minimally%20invasive%20necrosectomies%20were%20performed%20in%20a%20cohort%20of%20577%20patients%20presenting%20over%20a%2050-month%20period.%20One%20patient%20in%20each%20group%20died%20in%20hospital.%20Overall%20median%20stay%20was%203.8%20days%20in%20the%20intensive%20care%20unit%20%28ICU%29%20and%2044%20days%20on%20the%20ward.%20The%20median%20overall%20treatment%20cost%20was%20US%2456674.%20The%20median%20largest%20contributors%20to%20this%20total%20were%20ward%20%2826.3%25%29%2C%20surgical%20personnel%20%2822.3%25%29%20and%20ICU%20%2817.0%25%29%20costs.%20These%20did%20not%20differ%20statistically%20between%20the%20two%20treatment%20modalities.%5CnConclusions%5CnPancreatic%20necrosectomy%20uses%20considerable%20health%20care%20resources.%20Minimally%20invasive%20techniques%20have%20not%20been%20shown%20to%20reduce%20costs.%20Any%20intervention%20that%20can%20reduce%20the%20length%20of%20hospital%20and%2C%20in%20particular%2C%20ICU%20stay%20by%20reducing%20the%20incidence%20of%20organ%20failure%20or%20by%20preventing%20secondary%20infection%20is%20likely%20to%20be%20cost-effective.%22%2C%22date%22%3A%22March%201%2C%202011%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1111%5C%2Fj.1477-2574.2010.00267.x%22%2C%22ISSN%22%3A%221365-182X%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS1365182X15304202%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-09-02T03%3A27%3A28Z%22%7D%7D%2C%7B%22key%22%3A%222BZ3N4QS%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Yeh%20et%20al.%22%2C%22parsedDate%22%3A%222014-09-28%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EYeh%2C%20J.%20L.%2C%20Wu%2C%20S.%20%26amp%3B%20Wu%2C%20B.%20U.%20Regional%20cost%20variation%20for%20acute%20pancreatitis%20in%20the%20U.S.%20%3Ci%3EJOP%3C%5C%2Fi%3E%20%3Cb%3E15%3C%5C%2Fb%3E%2C%20448%26%23x2013%3B454%20%282014%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Regional%20cost%20variation%20for%20acute%20pancreatitis%20in%20the%20U.S%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20L.%22%2C%22lastName%22%3A%22Yeh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Su%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bechien%20U.%22%2C%22lastName%22%3A%22Wu%22%7D%5D%2C%22abstractNote%22%3A%22CONTEXT%3A%20Acute%20pancreatitis%20is%20one%20of%20the%20most%20common%20causes%20for%20acute%20hospitalization%20related%20to%20digestive%20disease.%5CnOBJECTIVES%3A%20This%20study%20aimed%20to%20examine%20regional%20variation%20in%20national%20healthcare%20expenditure%20for%20management%20of%20acute%20pancreatitis.%5CnMETHODS%3A%20The%20Nationwide%20Inpatient%20Sample%20from%202010%20was%20utilized%20to%20examine%20hospitalizations%20for%20acute%20pancreatitis.%20Total%20costs%20per%20hospitalization%20were%20calculated%20from%20charges%20using%20a%20cost-to-charge%20ratio%20and%20adjusted%20for%20suspected%20cost%20determinants%20from%20multivariable%20regression%20analysis.%20States%20were%20then%20ranked%20by%20costs%20and%20divided%20into%20tertiles%20for%20evaluation%20of%20outcome%20measures%2C%20including%20in-hospital%20mortality.%5CnRESULTS%3A%20Acute%20pancreatitis%20accounted%20for%20288%2C597%20hospitalizations%20in%202010.%20Regional%20variation%20was%20demonstrated%20after%20adjustment%20with%20a%20mean%20cost%20per%20hospitalization%20of%20%2412%2C446.48.%20There%20was%20a%20difference%20of%20%244%2C870%20per%20hospitalization%20between%20states%20in%20low%20cost%20and%20high%20cost%20tertiles.%20High%20cost%20states%20had%20a%20greater%20use%20of%20mechanical%20ventilation%20and%20infusion%20of%20supplemental%20nutrition%20%28P%26lt%3B0.0001%29.%20Despite%20these%20differences%2C%20in-hospital%20mortality%20remained%20similar%20across%20cost%20tertiles%20%28P%3D0.44%29.%20Several%20low-cost%20states%20were%20identified%20in%20traditionally%20high-cost%20regions.%5CnCONCLUSIONS%3A%20Significant%20regional%20variation%20in%20costs%20for%20acute%20pancreatitis%20persisted%20after%20adjusting%20for%20patient%20demographics%2C%20hospital%20characteristics%20and%20case%20mix%20variables.%20This%20variation%20suggests%20opportunities%20for%20increasing%20efficiency%20without%20compromising%20quality%20of%20care%20for%20acute%20pancreatitis.%22%2C%22date%22%3A%22Sep%2028%2C%202014%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.6092%5C%2F1590-8577%5C%2F2797%22%2C%22ISSN%22%3A%221590-8577%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-09-02T03%3A13%3A35Z%22%7D%7D%2C%7B%22key%22%3A%222M39MNKT%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pie%5Cu0144kowska%20et%20al.%22%2C%22parsedDate%22%3A%222016-01-19%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPie%26%23x144%3Bkowska%2C%20J.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20Perfusion-CT%20-%20Can%20We%20Predict%20Acute%20Pancreatitis%20Outcome%20within%20the%20First%2024%20Hours%20from%20the%20Onset%20of%20Symptoms%3F%20%3Ci%3EPLoS%20One%3C%5C%2Fi%3E%20%3Cb%3E11%3C%5C%2Fb%3E%2C%20%282016%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Perfusion-CT%20-%20Can%20We%20Predict%20Acute%20Pancreatitis%20Outcome%20within%20the%20First%2024%20Hours%20from%20the%20Onset%20of%20Symptoms%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joanna%22%2C%22lastName%22%3A%22Pie%5Cu0144kowska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katarzyna%22%2C%22lastName%22%3A%22Gwo%5Cu017adziewicz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katarzyna%22%2C%22lastName%22%3A%22Skrobisz-Balandowska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Iwona%22%2C%22lastName%22%3A%22Marek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Justyna%22%2C%22lastName%22%3A%22Kostro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edyta%22%2C%22lastName%22%3A%22Szurowska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Micha%5Cu0142%22%2C%22lastName%22%3A%22Studniarek%22%7D%5D%2C%22abstractNote%22%3A%22Purpose%5CnSevere%20acute%20pancreatitis%20%28AP%29%20is%20still%20a%20significant%20clinical%20problem%20which%20is%20associated%20with%20a%20highly%20mortality.%20The%20aim%20of%20this%20study%20was%20the%20evaluation%20of%20prognostic%20value%20of%20CT%20regional%20perfusion%20measurement%20performed%20on%20the%20first%20day%20of%20onset%20of%20symptoms%20of%20AP%2C%20in%20assessing%20the%20risk%20of%20developing%20severe%20form%20of%20acute%20pancreatitis.%5Cn%5CnMaterial%20and%20Methods%5Cn79%20patients%20with%20clinical%20symptoms%20and%20biochemical%20criteria%20indicative%20of%20acute%20pancreatitis%20%28acute%20upper%20abdominal%20pain%2C%20elevated%20levels%20of%20serum%20amylase%20and%20lipase%29%20underwent%20perfusion%20CT%20within%2024%20hours%20after%20onset%20of%20symptoms.%20The%20follow-up%20examinations%20were%20performed%20after%204%5Cu20136%20days%20to%20detect%20progression%20of%20the%20disease.%20Perfusion%20parameters%20were%20compared%20in%2041%20people%20who%20developed%20severe%20form%20of%20AP%20%28pancreatic%20and%5C%2For%20peripancreatic%20tissue%20necrosis%29%20with%20parameters%20in%2038%20consecutive%20patients%20in%20whom%20course%20of%20AP%20was%20mild.%20Blood%20flow%2C%20blood%20volume%2C%20mean%20transit%20time%20and%20permeability%20surface%20area%20product%20were%20calculated%20in%20the%20three%20anatomic%20pancreatic%20subdivisions%20%28head%2C%20body%20and%20tail%29.%20At%20the%20same%20time%20the%20patient%27s%20clinical%20status%20was%20assessed%20by%20APACHE%20II%20score%20and%20laboratory%20parameters%20such%20as%20CRP%2C%20serum%20lipase%20and%20amylase%2C%20AST%2C%20ALT%2C%20GGT%2C%20ALP%20and%20bilirubin%20were%20compared.%5Cn%5CnResults%5CnStatistical%20differences%20in%20the%20perfusion%20parameters%20between%20the%20group%20of%20patients%20with%20mild%20and%20severe%20AP%20were%20shown.%20Blood%20flow%2C%20blood%20volume%20and%20mean%20transit%20time%20were%20significantly%20lower%20and%20permeability%20surface%20area%20product%20was%20significantly%20higher%20in%20patients%20who%20develop%20severe%20acute%20pancreatitis%20and%20presence%20of%20pancreatic%20and%5C%2For%20peripancreatic%20necrosis%20due%20to%20pancreatic%20ischemia.%20There%20were%20no%20statistically%20significant%20differences%20between%20the%20two%20groups%20in%20terms%20of%20evaluated%20on%20admission%20severity%20of%20pancreatitis%20assessed%20using%20APACHE%20II%20score%20and%20laboratory%20tests.%5Cn%5CnConclusions%5CnCT%20perfusion%20is%20a%20very%20useful%20indicator%20for%20prediction%20and%20selection%20patients%20in%20early%20stages%20of%20acute%20pancreatitis%20who%20are%20at%20risk%20of%20developing%20pancreatic%20and%5C%2For%20peripancreatic%20necrosis%20already%20on%20the%20first%20day%20of%20the%20onset%20of%20symptoms%20and%20can%20be%20used%20for%20treatment%20planning%20and%20monitoring%20of%20therapy%20of%20acute%20pancreatitis.%20Early%20suspicion%20of%20possible%20pancreatic%20necrosis%20both%20on%20the%20basis%20of%20scores%20based%20on%20clinical%20status%20and%20laboratory%20tests%20have%20low%20predictive%20value.%22%2C%22date%22%3A%222016-1-19%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0146965%22%2C%22ISSN%22%3A%221932-6203%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-22T01%3A40%3A12Z%22%7D%7D%2C%7B%22key%22%3A%222VB64822%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Tsuji%20et%20al.%22%2C%22parsedDate%22%3A%222012%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ETsuji%2C%20Y.%2C%20Takahashi%2C%20N.%20%26amp%3B%20Tsutomu%2C%20C.%20Pancreatic%20Perfusion%20CT%20in%20Early%20Stage%20of%20Severe%20Acute%20Pancreatitis.%20%3Ci%3EInt%20J%20Inflam%3C%5C%2Fi%3E%20%3Cb%3E2012%3C%5C%2Fb%3E%2C%20%282012%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Pancreatic%20Perfusion%20CT%20in%20Early%20Stage%20of%20Severe%20Acute%20Pancreatitis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yoshihisa%22%2C%22lastName%22%3A%22Tsuji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naoki%22%2C%22lastName%22%3A%22Takahashi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chiba%22%2C%22lastName%22%3A%22Tsutomu%22%7D%5D%2C%22abstractNote%22%3A%22Early%20intensive%20care%20for%20severe%20acute%20pancreatitis%20is%20essential%20for%20improving%20SAP%20mortality%20rates.%20However%2C%20intensive%20therapies%20for%20SAP%20are%20often%20delayed%20because%20there%20is%20no%20ideal%20way%20to%20accurately%20evaluate%20severity%20in%20the%20early%20stages.%20Currently%2C%20perfusion%20CT%20has%20been%20shown%20useful%20to%20predict%20prognosis%20of%20SAP%20in%20the%20early%20stage.%20In%20this%20presented%20paper%2C%20we%20would%20like%20to%20review%20the%20clinical%20usefulness%20and%20limitations%20of%20perfusion%20CT%20for%20evaluation%20of%20local%20and%20systemic%20complications%20in%20early%20stage%20of%20SAP.%22%2C%22date%22%3A%222012%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1155%5C%2F2012%5C%2F497386%22%2C%22ISSN%22%3A%222090-8040%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-22T01%3A39%3A35Z%22%7D%7D%2C%7B%22key%22%3A%224NTZ5ENV%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Munigala%20et%20al.%22%2C%22parsedDate%22%3A%222017-08%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMunigala%2C%20S.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20Predictors%20for%20early%20readmission%20in%20acute%20pancreatitis%20%28AP%29%20in%20the%20United%20States%20%28US%29%20-%20A%20nationwide%20population%20based%20study.%20%3Ci%3EPancreatology%3C%5C%2Fi%3E%20%3Cb%3E17%3C%5C%2Fb%3E%2C%20534%26%23x2013%3B542%20%282017%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Predictors%20for%20early%20readmission%20in%20acute%20pancreatitis%20%28AP%29%20in%20the%20United%20States%20%28US%29%20-%20A%20nationwide%20population%20based%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Satish%22%2C%22lastName%22%3A%22Munigala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Divya%22%2C%22lastName%22%3A%22Subramaniam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dipti%20P.%22%2C%22lastName%22%3A%22Subramaniam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paula%22%2C%22lastName%22%3A%22Buchanan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hong%22%2C%22lastName%22%3A%22Xian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Burroughs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guru%22%2C%22lastName%22%3A%22Trikudanathan%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%20%26%20AIMS%3A%20Population%20based%20data%20on%20the%20burden%20and%20patterns%20of%20acute%20pancreatitis%20%28AP%29%20early%20readmissions%20%28%5Cu226430-days%29%20are%20limited.%5CnMETHODS%3A%202013%20Nationwide%20Readmission%20Database%20%28NRD%29%20was%20queried.%20AP%20etiology%20was%20determined%20using%20associated%20diagnoses%20codes.%20Proportion%2C%20reasons%20for%20readmission%2C%20and%20associated%20costs%20were%20evaluated.%20Multivariate%20logistic%20regression%20analysis%20was%20performed%20to%20identify%20independent%20predictors%20for%2030-day%20readmission.%5CnRESULTS%3A%20After%20exclusions%2C%20we%20identified%20178%2C541%20patients%20with%20primary%20diagnosis%20of%20AP%20%28mean%20age%2053%5Cu00a0%5Cu00b1%5Cu00a017%20years%2C%2051%25%20male%29.%2013.7%25%20were%20readmitted%20%5Cu226430%20days%20%5B7.1%25%20in%20acute%20biliary%20pancreatitis%20%28ABP%29%20patients%20with%20index%20cholecystectomy%20%28CCY%29%2C%2016.3%25%20in%20ABP%20patients%20without%20CCY%2C%20and%2014.3%25%20in%20non-biliary%20AP%20patients%20%28p%5Cu00a0%3C%5Cu00a00.0001%29%5D.%20Reasons%20for%20readmission%20included%20AP%2C%20chronic%20pancreatitis%2C%20Pseudocyst%5C%2Fwalled%20off%20necrosis%2C%20biliary%20tract%20disease%2C%20smoldering%20symptoms%20and%20others.%20On%20multivariate%20analysis%20male%20gender%2C%20comorbidity%20status%20%28%5Cu22653%29%2C%20non-biliary%20etiology%2C%20organ%20failure%2C%20Pseudocyst%5C%2Fwalled%20off%20necrosis%20complications%2C%20and%20patients%20discharged%20to%20extended%20care%20facilities%20were%20associated%20with%20increased%20risk%20of%20readmission.%20ABP%20patients%20with%20index%20CCY%20had%20a%20significantly%20lower%20risk%20of%20early%20unplanned%20readmission%20%28odds%20ratio%200.45%2C%20p%5Cu00a0%3C%5Cu00a00.0001%29%20but%20ABP%20patients%20with%20index%20ERCP%20did%20not%20%28p%5Cu00a0%3D%5Cu00a00.96%29.%5CnCONCLUSIONS%3A%20About%201%20in%207%20AP%20patients%20had%20a%2030-day%20readmission%20after%20index%20hospitalization%20and%20about%20half%20of%20these%20were%20related%20to%20AP.%20Our%20data%20confirms%20the%20higher%20risk%20of%20readmission%20in%20alcohol%20and%20idiopathic%20AP%20and%20a%20lower%20risk%20in%20ABP.%20Risk%20of%20early%20unplanned%20readmission%20is%20significantly%20lower%20in%20ABP%20patients%20who%20underwent%20CCY%20and%20not%20ERCP%20during%20index%20hospitalization.%20Cholecystectomy%20should%20be%20performed%20in%20all%20ABP%20patients%20as%20per%20recommended%20guidelines.%22%2C%22date%22%3A%222017%20Jul%20-%20Aug%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.pan.2017.05.391%22%2C%22ISSN%22%3A%221424-3911%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-22T01%3A11%3A53Z%22%7D%7D%2C%7B%22key%22%3A%22QBCVUL98%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Green%20et%20al.%22%2C%22parsedDate%22%3A%222017-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGreen%2C%20R.%2C%20Charman%2C%20S.%20C.%20%26amp%3B%20Palser%2C%20T.%20Early%20definitive%20treatment%20rate%20as%20a%20quality%20indicator%20of%20care%20in%20acute%20gallstone%20pancreatitis.%20%3Ci%3EBr%20J%20Surg%3C%5C%2Fi%3E%20%3Cb%3E104%3C%5C%2Fb%3E%2C%201686%26%23x2013%3B1694%20%282017%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Early%20definitive%20treatment%20rate%20as%20a%20quality%20indicator%20of%20care%20in%20acute%20gallstone%20pancreatitis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Green%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20C.%22%2C%22lastName%22%3A%22Charman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%22%2C%22lastName%22%3A%22Palser%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Early%20definitive%20treatment%20%28cholecystectomy%20or%20endoscopic%20sphincterotomy%20in%20the%20same%20admission%20or%20within%202%20weeks%20after%20discharge%29%20of%20gallstone%20disease%20after%20a%20biliary%20attack%20of%20acute%20pancreatitis%20is%20standard%20of%20care.%20This%20study%20investigated%20whether%20compliance%20with%20early%20definitive%20treatment%20for%20acute%20gallstone%20pancreatitis%20can%20be%20used%20as%20a%20care%20quality%20indicator%20for%20the%20condition.%5CnMETHODS%3A%20A%20retrospective%20cohort%20study%20was%20conducted%20using%20the%20Hospital%20Episode%20Statistics%20database.%20All%20emergency%20admissions%20to%20National%20Health%20Service%20hospitals%20in%20England%20with%20a%20first%20time%20diagnosis%20of%20acute%20gallstone%20pancreatitis%20in%20the%20financial%20years%202008%2C%202009%20and%202010%20were%20examined.%20Trends%20in%20early%20definitive%20treatment%20between%20hospital%20trusts%20were%20examined%20and%20patient%20morbidity%20outcomes%20were%20determined.%5CnRESULTS%3A%20During%20the%20study%20interval%20there%20were%2019%20510%20patients%20with%20an%20overall%20rate%20of%20early%20definitive%20treatment%20at%2034%5Cu00b77%20%28range%209%5Cu00b74-84%5Cu00b77%29%20per%20cent.%20In%20the%201-year%20follow-up%20period%2C%204661%20patients%20%2823%5Cu00b79%20per%20cent%29%20had%20one%20or%20more%20emergency%20readmissions%20for%20complications%20related%20to%20gallstone%20pancreatitis.%20Of%20these%2C%202692%20%2857%5Cu00b78%20per%20cent%29%20were%20readmissions%20for%20acute%20pancreatitis%3B%20911%20%2833%5Cu00b78%20per%20cent%29%20were%20within%20the%20first%202%20weeks%20of%20discharge%2C%20with%20the%20remaining%201781%20%2866%5Cu00b72%20per%20cent%29%20occurring%20after%20the%20point%20at%20which%20definitive%20treatment%20should%20have%20been%20received.%20Early%20definitive%20treatment%20resulted%20in%20a%2039%20per%20cent%20reduction%20in%20readmission%20risk%20%28adjusted%20risk%20ratio%20%28RR%29%200%5Cu00b761%2C%2095%20per%20cent%20c.i.%200%5Cu00b758%20to%200%5Cu00b765%29.%20The%20risk%20was%20further%20reduced%20for%20acute%20pancreatitis%20readmissions%20to%2054%20per%20cent%20in%20the%20early%20definitive%20treatment%20group%20%28adjusted%20RR%200%5Cu00b746%2C%200%5Cu00b742%20to%200%5Cu00b751%29.%5CnCONCLUSION%3A%20In%20acute%20gallstone%20pancreatitis%2C%20compliance%20with%20recommended%20early%20definitive%20treatment%20varied%20considerably%2C%20with%20associated%20variation%20in%20outcomes.%20Compliance%20should%20be%20used%20as%20a%20quality%20indicator%20to%20improve%20care.%22%2C%22date%22%3A%22Nov%202017%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fbjs.10578%22%2C%22ISSN%22%3A%221365-2168%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-22T01%3A11%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22SQ4B9G2L%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Yadav%20et%20al.%22%2C%22parsedDate%22%3A%222015-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EYadav%2C%20A.%20K.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20Perfusion%20CT%3A%20can%20it%20predict%20the%20development%20of%20pancreatic%20necrosis%20in%20early%20stage%20of%20severe%20acute%20pancreatitis%3F%20%3Ci%3EAbdom%20Imaging%3C%5C%2Fi%3E%20%3Cb%3E40%3C%5C%2Fb%3E%2C%20488%26%23x2013%3B499%20%282015%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Perfusion%20CT%3A%20can%20it%20predict%20the%20development%20of%20pancreatic%20necrosis%20in%20early%20stage%20of%20severe%20acute%20pancreatitis%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajay%20Kumar%22%2C%22lastName%22%3A%22Yadav%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raju%22%2C%22lastName%22%3A%22Sharma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Devasenathipathy%22%2C%22lastName%22%3A%22Kandasamy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ashu%20Seith%22%2C%22lastName%22%3A%22Bhalla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shivanand%22%2C%22lastName%22%3A%22Gamanagatti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deep%20N.%22%2C%22lastName%22%3A%22Srivastava%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ashish%20Datt%22%2C%22lastName%22%3A%22Upadhyay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pramod%20Kumar%22%2C%22lastName%22%3A%22Garg%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%3A%20Pancreatic%20necrosis%20is%20an%20important%20determinant%20of%20patient%20outcome%20in%20severe%20acute%20pancreatitis%20%28SAP%29.%20This%20prospective%20study%20was%20conducted%20to%20evaluate%20if%20perfusion%20CT%20%28PCT%29%20can%20predict%20the%20development%20of%20necrosis%20at%20an%20early%20stage%20in%20SAP.%5CnMETHODS%3A%20PCT%20was%20performed%20within%2072%20h%20of%20abdominal%20pain%20in%2057%20consecutive%20admitted%20patients%20of%20acute%20pancreatitis%2C%20out%20of%20which%20four%20patients%20were%20excluded.%20Thirty-two%20patients%20were%20classified%20as%20SAP%20and%2021%20as%20mild%20acute%20pancreatitis%20%28MAP%29%20on%20the%20basis%20of%20APACHE%20II%20or%20SIRS%20criteria%20or%20presence%20of%20organ%20failure.%20All%20patients%20underwent%20a%20follow-up%20CECT%20at%203%20weeks%20to%20look%20for%20pancreatic%20necrosis.%5CnRESULTS%3A%20Out%20of%2032%20patients%20of%20SAP%2C%2014%20patients%20showed%20perfusion%20defects.%20The%20mean%20blood%20flow%20%28BF%29%20in%20these%20areas%20was%2011.47%20%5Cu00b1%205.56%20mL%5C%2F100%20mL%5C%2Fmin%20and%20median%20blood%20volume%20%28BV%29%20was%203.92%20mL%5C%2F100%20mL%20%280.5-8.49%20mL%5C%2F100%20mL%29.%20All%20these%20patients%20developed%20necrosis%20on%20follow-up%20scan.%20Two%20patients%20who%20did%20not%20show%20perfusion%20defects%20also%20developed%20necrosis.%20Remaining%2037%20patients%20%2816%20SAP%20and%2021%20MAP%29%20did%20not%20show%20perfusion%20defect%20and%20did%20not%20develop%20necrosis%20on%20follow-up.%20All%20regions%20showing%20BF%20less%20than%20%5Cu226423.45%20mL%5C%2F100%20mL%5C%2Fmin%20and%20BV%20%5Cu22648.49%20mL%5C%2F100%20mL%20developed%20pancreatic%20necrosis.%20The%20values%20of%20perfusion%20parameters%20may%20vary%20with%20the%20scanner%2C%20mathematical%20model%20and%20protocol%20used.%20The%20sensitivity%20and%20specificity%20of%20PCT%20for%20predicting%20pancreatic%20necrosis%20were%2087.5%25%20and%20100%25%2C%20respectively.%20The%20cut%20off%20values%20of%20BF%20and%20BV%20for%20predicting%20the%20development%20of%20pancreatic%20necrosis%20were%2027.29%20mL%5C%2F100%20mL%5C%2Fmin%20and%208.96%20mL%5C%2F100%20mL%2C%20respectively%2C%20based%20on%20ROC%20curve.%20PCT%20is%20a%20reliable%20tool%20for%20early%20prediction%20of%20pancreatic%20necrosis%2C%20which%20may%20open%20new%20avenues%20to%20prevent%20this%20ominous%20complication.%22%2C%22date%22%3A%22Mar%202015%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs00261-014-0226-6%22%2C%22ISSN%22%3A%221432-0509%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-22T01%3A11%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22HSZ9MZGZ%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Tsuji%20et%20al.%22%2C%22parsedDate%22%3A%222007-12%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ETsuji%2C%20Y.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20Perfusion%20computerized%20tomography%20can%20predict%20pancreatic%20necrosis%20in%20early%20stages%20of%20severe%20acute%20pancreatitis.%20%3Ci%3EClin.%20Gastroenterol.%20Hepatol.%3C%5C%2Fi%3E%20%3Cb%3E5%3C%5C%2Fb%3E%2C%201484%26%23x2013%3B1492%20%282007%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Perfusion%20computerized%20tomography%20can%20predict%20pancreatic%20necrosis%20in%20early%20stages%20of%20severe%20acute%20pancreatitis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yoshihisa%22%2C%22lastName%22%3A%22Tsuji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hiroshi%22%2C%22lastName%22%3A%22Yamamoto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shujiro%22%2C%22lastName%22%3A%22Yazumi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuji%22%2C%22lastName%22%3A%22Watanabe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kazuhiro%22%2C%22lastName%22%3A%22Matsueda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hiroyuki%22%2C%22lastName%22%3A%22Yamamoto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tsutomu%22%2C%22lastName%22%3A%22Chiba%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%20%26%20AIMS%3A%20The%20mortality%20rate%20associated%20with%20severe%20acute%20pancreatitis%20%28SAP%29%20with%20necrosis%20remains%20high%20because%20early%20prediction%20of%20pancreatic%20necrosis%20is%20difficult.%20We%20evaluated%20whether%20perfusion%20computerized%20tomography%20%28CT%29%2C%20which%20is%20used%20to%20identify%20early%20stage%20ischemia%20in%20the%20brain%2C%20could%20detect%20ischemic%20changes%20in%20the%20pancreas%20in%20the%20early%20stages%20of%20SAP%20and%20predict%20development%20of%20necrosis.%5CnPATIENTS%20AND%20METHODS%3A%20Thirty%20consecutive%20patients%20with%20a%20diagnosis%20of%20SAP%20according%20to%20the%20Atlanta%20criteria%20and%20whose%20score%20was%20greater%20than%206%20were%20enrolled%20in%20this%20study.%20All%20patients%20were%20hospitalized%20within%203%20days%20after%20onset%20of%20symptoms%20indicative%20of%20acute%20pancreatitis%20and%20underwent%20perfusion%20CT.%20Three%20weeks%20later%2C%20all%20patients%20underwent%20conventional%20contrast-enhanced%20CT%20to%20detect%20progression%20of%20their%20disease.%5CnRESULTS%3A%20Perfusion%20CT%20showed%20that%2010%20of%20the%2030%20patients%20had%20pancreatic%20ischemia%20at%20the%20time%20of%20diagnosis.%20Contrast-enhanced%20CT%20disclosed%20that%20pancreatic%20necrosis%20developed%20in%209%20of%20these%2010%20patients%2C%20but%20not%20in%20the%2020%20patients%20who%20did%20not%20have%20pancreatic%20ischemia.%20The%20sensitivity%20and%20specificity%20of%20perfusion%20CT%20for%20predicting%20pancreatic%20necrosis%20was%20calculated%20to%20be%20100%25%20and%2095.3%25%2C%20respectively.%5CnCONCLUSIONS%3A%20Perfusion%20CT%20is%20a%20useful%20tool%20for%20early%20detection%20of%20ischemic%20changes%20in%20the%20pancreas%20that%20lead%20to%20pancreatic%20necrosis.%22%2C%22date%22%3A%22Dec%202007%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cgh.2007.07.014%22%2C%22ISSN%22%3A%221542-7714%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-22T01%3A10%3A48Z%22%7D%7D%2C%7B%22key%22%3A%22WZDGVQ4S%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hussain%20et%20al.%22%2C%22parsedDate%22%3A%221998-12%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EHussain%2C%20N.%2C%20Wu%2C%20F.%2C%20Zhu%2C%20L.%2C%20Thrall%2C%20R.%20S.%20%26amp%3B%20Kresch%2C%20M.%20J.%20Neutrophil%20apoptosis%20during%20the%20development%20and%20resolution%20of%20oleic%20acid-induced%20acute%20lung%20injury%20in%20the%20rat.%20%3Ci%3EAm.%20J.%20Respir.%20Cell%20Mol.%20Biol.%3C%5C%2Fi%3E%20%3Cb%3E19%3C%5C%2Fb%3E%2C%20867%26%23x2013%3B874%20%281998%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Neutrophil%20apoptosis%20during%20the%20development%20and%20resolution%20of%20oleic%20acid-induced%20acute%20lung%20injury%20in%20the%20rat%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Hussain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Zhu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20S.%22%2C%22lastName%22%3A%22Thrall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20J.%22%2C%22lastName%22%3A%22Kresch%22%7D%5D%2C%22abstractNote%22%3A%22The%20oleic%20acid%20%28OA%29%20model%20of%20acute%20lung%20injury%20in%20rats%20is%20characterized%20by%20a%20massive%20and%20rapid%20influx%20of%20polymorphonuclear%20neutrophils%20%28PMN%29%20within%201%20h%2C%20with%20a%20peak%20inflammatory%20response%20at%204%20h%20and%20resolution%20by%2072%20h.%20We%20hypothesized%20that%20PMN%20apoptosis%20is%20involved%20in%20the%20resolution%20of%20OA-induced%20acute%20lung%20injury.%20To%20test%20this%20hypothesis%2C%20healthy%20adult%20Fischer%20344%20rats%20were%20given%2030%20microl%20OA%20in%200.1%25%20bovine%20serum%20albumin%20%28BSA%29%20intravenously%3B%20controls%20were%20given%20BSA%20alone%20and%20killed%20at%201%2C%204%2C%2024%2C%20and%2072%20h%20after%20OA%20to%20obtain%20bronchoalveolar%20lavage%20fluid%20%28BALF%29%20and%20lung%20tissue.%20Cell%20pellets%20from%20BALF%20and%20formalin-fixed%2C%20paraffin-embedded%20tissue%20section%20samples%20were%20processed%20for%20terminal%20deoxyribonucleotidyl%20transferase-mediated%20dUTP-biotin%20nick%20end%20labeling%20%28TUNEL%29%20to%20identify%20apoptotic%20cells.%20Propidium%20iodide%20was%20used%20to%20counterstain%20nuclei.%20Percentage%20of%20nuclei%20undergoing%20apoptosis%20was%20counted%20under%20a%20fluorescent%20microscope.%20Control%20rats%20showed%20only%20resident%20alveolar%20macrophages%20%28AM%29%20in%20the%20BALF%20with%20no%20apoptosis.%20At%20the%20peak%20of%20injury%2C%201%20h%20and%204%20h%20after%20OA%20injection%2C%20we%20observed%20a%20massive%20PMN%20response%20without%20any%20evidence%20of%20apoptosis.%20At%2024%20h%2C%20when%20the%20OA%20injury%20is%20clinically%20and%20histologically%20in%20early%20resolution%2C%20we%20observed%20intense%20apoptosis%20of%20PMN%20nuclei%20along%20with%20evidence%20of%20apoptotic%20bodies%20in%20the%20cytoplasm%20of%20AM.%20Some%20of%20the%20AM%20also%20showed%20apoptotic%20nuclei%20at%2072%20h.%20Similar%20observations%20were%20made%20in%20the%20lung%20tissue%20sections.%20The%20results%20of%20the%20TUNEL%20assay%20were%20confirmed%20by%20DNA%20ladders%20and%20electron%20microscopy.%20We%20conclude%20that%20apoptosis%20of%20PMN%20and%20clearance%20by%20AM%20is%20an%20important%20mechanism%20in%20resolution%20of%20OA-%20induced%20acute%20lung%20injury.%22%2C%22date%22%3A%22Dec%201998%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1165%5C%2Fajrcmb.19.6.3118%22%2C%22ISSN%22%3A%221044-1549%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-22T01%3A10%3A07Z%22%7D%7D%2C%7B%22key%22%3A%22YD8SBKKU%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Domschke%20et%20al.%22%2C%22parsedDate%22%3A%221993-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDomschke%2C%20S.%2C%20Malfertheiner%2C%20P.%2C%20Uhl%2C%20W.%2C%20B%26%23xFC%3Bchler%2C%20M.%20%26amp%3B%20Domschke%2C%20W.%20Free%20fatty%20acids%20in%20serum%20of%20patients%20with%20acute%20necrotizing%20or%20edematous%20pancreatitis.%20%3Ci%3EInt.%20J.%20Pancreatol.%3C%5C%2Fi%3E%20%3Cb%3E13%3C%5C%2Fb%3E%2C%20105%26%23x2013%3B110%20%281993%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Free%20fatty%20acids%20in%20serum%20of%20patients%20with%20acute%20necrotizing%20or%20edematous%20pancreatitis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Domschke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Malfertheiner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%22%2C%22lastName%22%3A%22Uhl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22B%5Cu00fcchler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%22%2C%22lastName%22%3A%22Domschke%22%7D%5D%2C%22abstractNote%22%3A%22Serum%20concentrations%20of%20free%20fatty%20acids%20%28FFA%29%20were%20assayed%20in%2020%20patients%20with%20acute%20necrotizing%20pancreatitis%20%28ANP%29.%20Pancreatic%20and%20peripancreatic%20fat%20necrosis%20was%20verified%20on%20operation%20and%5C%2For%20by%20contrast-enhanced%20computed%20tomography.%20For%20comparison%2C%2020%20patients%20with%20acute%20edematous%20pancreatitis%20%28AEP%29%20were%20examined.%20On%20admission%2C%20FFA%20serum%20levels%20were%201.14%20%2B%5C%2F-%200.12%20%28SEM%29%20mmol%5C%2FL%20in%20ANP%20and%2C%20thus%2C%20significantly%20%28p%20%3C%200.03%29%20higher%20than%20in%20AEP%20%280.78%20%2B%5C%2F-%200.09%20mmol%5C%2FL%29.%20The%20two%20groups%20also%20differed%20in%20the%20later%20course%3A%20in%20ANP%2C%20the%20FFA%20values%20remained%20raised%20%28d%205-11%3A0.86%20%2B%5C%2F-%200.13%20mmol%5C%2FL%3B%20p%20%3E%200.05%20vs%20day%201%29%2C%20whereas%20in%20AEP%2C%20the%20FFA%20concentrations%20normalized%20within%201%20wk%20%28d%202-4%3A0.52%20%2B%5C%2F-%200.11%20mmol%5C%2FL%3B%20d%205-11%3A0.39%20%2B%5C%2F-%200.05%20mmol%5C%2FL%3B%20p%20%3C%200.05%20vs%20day%201%20and%20p%20%3C%200.01%20vs%20ANP%29.%20Serum%20FFA%20correlated%20positively%20with%20C-reactive%20protein%20levels%20%28rs%20%3D%200.42%3B%20p%20%3C%200.01%29%2C%20but%20has%20less%20discriminating%20potency%20between%20ANP%20and%20AEP.%20In%20AEP%2C%20the%20initial%20peak%20may%20correspond%20to%20the%20disease%20outburst%20itself%20and%20to%20unspecific%20stress.%20In%20ANP%2C%20the%20higher%20and%20sustained%20elevation%20of%20FFA%20may%20predominantly%20mirror%20the%20ongoing%20pancreatic%20parenchymal%20and%20extrapancreatic%20fat%20necrosis%2C%20and%20be%20pathophysiologically%20relevant%2C%20especially%20in%20view%20of%20significantly%20reduced%20serum%20albumin%20levels%20in%20ANP.%22%2C%22date%22%3A%22Apr%201993%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2FBF02786078%22%2C%22ISSN%22%3A%220169-4197%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-22T01%3A09%3A48Z%22%7D%7D%2C%7B%22key%22%3A%22SHLAXW2I%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sztefko%20and%20Panek%22%2C%22parsedDate%22%3A%222001%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESztefko%2C%20K.%20%26amp%3B%20Panek%2C%20J.%20Serum%20free%20fatty%20acid%20concentration%20in%20patients%20with%20acute%20pancreatitis.%20%3Ci%3EPancreatology%3C%5C%2Fi%3E%20%3Cb%3E1%3C%5C%2Fb%3E%2C%20230%26%23x2013%3B236%20%282001%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Serum%20free%20fatty%20acid%20concentration%20in%20patients%20with%20acute%20pancreatitis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Sztefko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Panek%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20involvement%20of%20lipolytic%20enzymes%20and%20liberated%20fatty%20acids%20in%20ethiology%20of%20acute%20pancreatitis%20%28AP%29%20has%20been%20implicated.%5CnAIM%3A%20To%20analyze%20the%20level%20of%20FFA%20in%20the%20patients%20with%20AP%20in%20relation%20to%20severity%20of%20the%20disease.%5CnMATERIAL%20AND%20METHODS%3A%20The%20study%20included%2036%20patients%20with%20acute%20edematous%20AP%20%28group%20I%29%2C%2029%20patients%20with%20necrotizing%20AP%3A%2016%20without%20%28group%20IIA%29%20and%2013%20with%20complications%20%28group%20IIB%29%2C%20and%2012%20control%20subjects.%20Serum%20levels%20of%20total%20FFA%20%28by%20enzymatic%20method%29%20and%20the%20individual%20fatty%20acids%20of%20the%20FFA%20pool%20%28by%20gas-liquid%20chromatography%29%20were%20measured%20during%20the%20first%204%20days%20after%20admission.%5CnRESULTS%3A%20A%20significant%20increase%20in%20the%20mean%20total%20serum%20FFA%20was%20noted%20for%20all%20the%20groups%20with%20the%20highest%20values%20on%20admission%20%28p%20%3C%200.02-0.01%29.%20The%20per%20cent%20contribution%20was%20significantly%20higher%20as%20compared%20to%20control%20group%20for%20oleic%20acid%20%28group%20I%2C%20p%20%3C%200.02%2C%20group%20IIA%2C%20p%20%3C%200.05%2C%20group%20IIB%2C%20p%20%3C%200.005%29%2C%20linoleic%20acid%20%28group%20IIB%2C%20p%20%3C%200.02%29%20and%20arachidonic%20acid%20%28group%20IIA%2C%20p%20%3C%200.05%2C%20group%20IIB%2C%20p%20%3C%200.02%29.%20Significantly%20lower%20percentage%20was%20noted%20for%20stearic%20acid%20%28all%20three%20groups%3A%20p%20%3C%200.01%2C%20p%20%3C%200.005%2C%20p%20%3C%200.01%2C%20respectively%29%20and%20for%20palmitic%20acid%20%28only%20group%20IIB%3A%20p%20%3C%200.005%29.%20The%20ratio%20of%20saturated%20to%20polyunsaturated%20fatty%20acids%20was%20significantly%20lower%20than%20in%20control%20group%20on%20each%20day%20of%20study%20for%20group%20IIB%20only%20%28p%20%3C%200.005-p%20%3C%200.001%29.%5CnCONCLUSION%3A%20Polyunsaturated%20fatty%20acids%2C%20mainly%20linoleic%20and%20arachidonic%2C%20may%20be%20involved%20in%20the%20development%20of%20complications%20in%20acute%20pancreatitis.%22%2C%22date%22%3A%222001%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1159%5C%2F000055816%22%2C%22ISSN%22%3A%221424-3903%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-22T01%3A09%3A21Z%22%7D%7D%2C%7B%22key%22%3A%22BXWSSMHR%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Nordback%20and%20Lauslahti%22%2C%22parsedDate%22%3A%221986-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ENordback%2C%20I.%20%26amp%3B%20Lauslahti%2C%20K.%20Clinical%20pathology%20of%20acute%20necrotising%20pancreatitis.%20%3Ci%3EJ.%20Clin.%20Pathol.%3C%5C%2Fi%3E%20%3Cb%3E39%3C%5C%2Fb%3E%2C%2068%26%23x2013%3B74%20%281986%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Clinical%20pathology%20of%20acute%20necrotising%20pancreatitis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22I.%22%2C%22lastName%22%3A%22Nordback%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Lauslahti%22%7D%5D%2C%22abstractNote%22%3A%22Seventy%20nine%20pancreatic%20specimens%20were%20obtained%20from%20patients%20treated%20with%20pancreatic%20resection%20for%20acute%20necrotising%20pancreatitis.%20The%20necrotising%20process%20had%20started%20in%20the%20periphery%20of%20the%20gland%2C%20so%20that%20eight%20of%20seventy%20nine%20cases%20contained%20peripancreatic%20%28mainly%20fat%29%20necrosis%20only%20without%20any%20parenchymal%20necrosis.%20Peripheral%20parenchymal%20necrosis%20was%20characterised%20by%20a%20severe%20inflammatory%20reaction%2C%20with%20multinucleated%20leucocytes%20and%20microabscess.%20In%20the%20deep%20parts%20of%20the%20pancreas%20coagulation%20necrosis%20was%20found.%20Vascular%20changes%20%28thrombosis%2C%20vessel%20necrosis%29%20correlated%20with%20postoperative%20haemorrhagic%20complications%2C%20but%20they%20did%20not%20seem%20to%20have%20any%20important%20role%20in%20the%20necrotising%20process.%20The%20vascular%20changes%20seemed%20to%20be%20a%20secondary%20phenomenon.%20In%20clinical%20practice%20the%20most%20important%20aspects%20in%20reporting%20the%20histology%20of%20acute%20necrotising%20pancreatitis%20are%20the%20extent%20of%20parenchymal%20necrosis%2C%20because%20the%20surgeon%20may%20overestimate%20its%20extent%2C%20and%20the%20existence%20of%20vascular%20changes%2C%20because%20of%20the%20correlation%20with%20postoperative%20recovery.%22%2C%22date%22%3A%22Jan%201986%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1136%5C%2Fjcp.39.1.68%22%2C%22ISSN%22%3A%220021-9746%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-22T01%3A09%3A03Z%22%7D%7D%2C%7B%22key%22%3A%222ISW6MV5%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Balthazar%20et%20al.%22%2C%22parsedDate%22%3A%221990-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBalthazar%2C%20E.%20J.%2C%20Robinson%2C%20D.%20L.%2C%20Megibow%2C%20A.%20J.%20%26amp%3B%20Ranson%2C%20J.%20H.%20Acute%20pancreatitis%3A%20value%20of%20CT%20in%20establishing%20prognosis.%20%3Ci%3ERadiology%3C%5C%2Fi%3E%20%3Cb%3E174%3C%5C%2Fb%3E%2C%20331%26%23x2013%3B336%20%281990%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Acute%20pancreatitis%3A%20value%20of%20CT%20in%20establishing%20prognosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20J.%22%2C%22lastName%22%3A%22Balthazar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%20L.%22%2C%22lastName%22%3A%22Robinson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20J.%22%2C%22lastName%22%3A%22Megibow%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20H.%22%2C%22lastName%22%3A%22Ranson%22%7D%5D%2C%22abstractNote%22%3A%22The%20presence%20and%20degree%20of%20pancreatic%20necrosis%20%2830%25%2C%2050%25%2C%20or%20greater%20than%2050%25%29%20was%20evaluated%20by%20means%20of%20bolus%20injection%20of%20contrast%20material%20and%20dynamic%20sequential%20computed%20tomography%20%28CT%29%20in%2088%20patients%20with%20acute%20pancreatitis%20at%20initial%20and%20follow-up%20examinations.%20Pancreatic%20necrosis%20was%20defined%20as%20lack%20of%20enhancement%20of%20all%20or%20a%20portion%20of%20the%20gland.%20Length%20of%20hospitalization%2C%20morbidity%2C%20and%20mortality%20in%20patients%20with%20early%20or%20late%20necrosis%20%2822%20patients%29%20were%20evaluated%20and%20compared%20with%20the%20same%20criteria%20in%20the%20rest%20of%20the%20group.%20Patients%20with%20necrosis%20had%20a%2023%25%20mortality%20and%20an%2082%25%20complication%20rate%3B%20patients%20without%20necrosis%20had%200%25%20mortality%20and%206%25%20morbidity.%20When%20only%20the%20initial%20assessment%20was%20considered%2C%20patients%20with%20peripancreatic%20phlegmons%20and%20necrosis%20had%2080%25%20morbidity%2C%20compared%20with%2036%25%20morbidity%20in%20those%20with%20phlegmons%20and%20no%20necrosis.%20Serious%20complications%20occurred%20in%20patients%20who%20initially%20had%20or%20developed%20more%20than%2030%25%20necrosis.%20A%20CT%20severity%20index%2C%20based%20on%20a%20combination%20of%20peripancreatic%20inflammation%2C%20phlegmon%2C%20and%20degree%20of%20pancreatic%20necrosis%20as%20seen%20at%20initial%20CT%20study%2C%20was%20developed.%20Patients%20with%20a%20high%20CT%20severity%20index%20had%2092%25%20morbidity%20and%2017%25%20mortality%3B%20patients%20with%20a%20low%20CT%20severity%20index%20had%202%25%20morbidity%2C%20and%20none%20died.%22%2C%22date%22%3A%22Feb%201990%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1148%5C%2Fradiology.174.2.2296641%22%2C%22ISSN%22%3A%220033-8419%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-22T01%3A08%3A25Z%22%7D%7D%2C%7B%22key%22%3A%22UVSUL229%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Yoon%20et%20al.%22%2C%22parsedDate%22%3A%222017-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EYoon%2C%20S.%20B.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20Impact%20of%20body%20fat%20and%20muscle%20distribution%20on%20severity%20of%20acute%20pancreatitis.%20%3Ci%3EPancreatology%3C%5C%2Fi%3E%20%3Cb%3E17%3C%5C%2Fb%3E%2C%20188%26%23x2013%3B193%20%282017%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Impact%20of%20body%20fat%20and%20muscle%20distribution%20on%20severity%20of%20acute%20pancreatitis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Seung%20Bae%22%2C%22lastName%22%3A%22Yoon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moon%20Hyung%22%2C%22lastName%22%3A%22Choi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22In%20Seok%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chul-Hyun%22%2C%22lastName%22%3A%22Lim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jin%20Soo%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu%20Kyung%22%2C%22lastName%22%3A%22Cho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jae%20Myung%22%2C%22lastName%22%3A%22Park%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bo-In%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Young-Seok%22%2C%22lastName%22%3A%22Cho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Myung-Gyu%22%2C%22lastName%22%3A%22Choi%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%5C%2FOBJECTIVES%3A%20Obesity%20is%20a%20well-established%20risk%20factor%20for%20severe%20acute%20pancreatitis%20%28AP%29%3B%20however%2C%20the%20impact%20of%20visceral%20obesity%20or%20sarcopenic%20obesity%20on%20severity%20of%20AP%20has%20not%20been%20well%20studied.%20We%20compared%20the%20relationship%20between%20severity%20of%20AP%20and%20various%20body%20parameters%20including%20body%20weight%2C%20body%20mass%20index%20%28BMI%29%2C%20subcutaneous%20adipose%20tissue%20%28SAT%29%2C%20visceral%20adipose%20tissue%20%28VAT%29%2C%20and%20visceral%20fat-to-muscle%20ratio%20%28VMR%29.%5CnMETHODS%3A%20We%20analyzed%20the%20data%20of%20patients%20who%20were%20diagnosed%20with%20AP%20from%202009%20to%202015.%20Image%20analysis%20software%20program%20%28Aquarius%20Workstation%20software%29%20was%20used%20to%20calculate%20individual%20VAT%2C%20SAT%2C%20and%20skeletal%20muscle%20areas%20from%20abdominal%20computed%20tomography%20scans%20at%20L3%20vertebral%20levels.%20Revised%20Atlanta%20Classification%20was%20adopted%20to%20define%20severity%20of%20AP.%20Receiver%20operating%20characteristics%20%28ROC%29%20curves%20were%20constructed%20to%20determine%20the%20optimal%20threshold%20for%20predicting%20the%20severity.%5CnRESULTS%3A%20Among%20203%20patients%2C%2013%20%286.4%25%29%20patients%20had%20severe%20AP%20and%2062%20%2830.5%25%29%20patients%20had%20moderately%20severe%20cases.%20VMR%20demonstrated%20the%20highest%20area%20under%20the%20ROC%20curve%20%5B0.757%2C%20%2895%25%20confidence%20interval%3A%200.689-0.825%29%5D%20in%20predicting%20moderately%20severe%20or%20severe%20AP.%20The%20optimal%20threshold%20of%20VMR%20for%20predicting%20severity%20was%201.%20The%20prevalence%20of%20various%20local%20complications%20and%20persistent%20organ%20failure%20were%20higher%20in%20patients%20with%20VMR%20over%201.%5CnCONCLUSIONS%3A%20High%20visceral%20fat%20with%20low%20skeletal%20muscle%20volume%20was%20strongly%20correlated%20with%20AP%20severity.%20VMR%20had%20a%20stronger%20correlation%20with%20AP%20severity%20than%20body%20weight%20or%20BMI.%20This%20simple%20grading%20system%20would%20be%20useful%20if%20incorporated%20into%20future%20predictive%20scoring%20models.%22%2C%22date%22%3A%222017%20Mar%20-%20Apr%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.pan.2017.02.002%22%2C%22ISSN%22%3A%221424-3911%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-22T01%3A08%3A00Z%22%7D%7D%2C%7B%22key%22%3A%22UFISP9UZ%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Yashima%20et%20al.%22%2C%22parsedDate%22%3A%222011-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EYashima%2C%20Y.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20A%20large%20volume%20of%20visceral%20adipose%20tissue%20leads%20to%20severe%20acute%20pancreatitis.%20%3Ci%3EJ.%20Gastroenterol.%3C%5C%2Fi%3E%20%3Cb%3E46%3C%5C%2Fb%3E%2C%201213%26%23x2013%3B1218%20%282011%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20large%20volume%20of%20visceral%20adipose%20tissue%20leads%20to%20severe%20acute%20pancreatitis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yoko%22%2C%22lastName%22%3A%22Yashima%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hiroyuki%22%2C%22lastName%22%3A%22Isayama%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takeshi%22%2C%22lastName%22%3A%22Tsujino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rie%22%2C%22lastName%22%3A%22Nagano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keisuke%22%2C%22lastName%22%3A%22Yamamoto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suguru%22%2C%22lastName%22%3A%22Mizuno%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hiroshi%22%2C%22lastName%22%3A%22Yagioka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kazumichi%22%2C%22lastName%22%3A%22Kawakubo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takashi%22%2C%22lastName%22%3A%22Sasaki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hirofumi%22%2C%22lastName%22%3A%22Kogure%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yousuke%22%2C%22lastName%22%3A%22Nakai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenji%22%2C%22lastName%22%3A%22Hirano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naoki%22%2C%22lastName%22%3A%22Sasahira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Minoru%22%2C%22lastName%22%3A%22Tada%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takao%22%2C%22lastName%22%3A%22Kawabe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kazuhiko%22%2C%22lastName%22%3A%22Koike%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Masao%22%2C%22lastName%22%3A%22Omata%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Obesity%20plays%20an%20important%20role%20in%20acute%20pancreatitis.%20Assuming%20that%20the%20volume%20of%20visceral%20adipose%20tissue%20%28VAT%29%20directly%20influences%20the%20severity%20of%20acute%20pancreatitis%2C%20we%20investigated%20the%20relationship%20between%20VAT%20and%20acute%20pancreatitis.%5CnMETHODS%3A%20Data%20were%20collected%20consecutively%20from%20124%20patients%20who%20were%20diagnosed%20with%20acute%20pancreatitis.%20Body%20mass%20index%20%28BMI%29%20was%20calculated%20from%20the%20database.%20Computed%20tomography%20was%20performed%20in%20all%20patients%2C%20and%20VAT%2C%20subcutaneous%20adipose%20tissue%20%28SAT%29%2C%20and%20waist%20circumference%20%28WC%29%20were%20measured%20at%20the%20level%20of%20the%20intervertebral%20disk%20between%20L2%20and%20L3.%20Atlanta%20criteria%20were%20adopted%20to%20define%20severe%20acute%20pancreatitis.%20Clinical%20courses%20were%20investigated%2C%20and%20the%20Ranson%20and%20acute%20physiology%20and%20chronic%20health%20evaluation%20II%20%28APACHE%20II%29%20scores%20were%20calculated%20for%20all%20patients.%5CnRESULTS%3A%20Forty-eight%20patients%20had%20severe%20acute%20pancreatitis%20%2838.7%25%29%2C%20and%2076%20were%20mild%20cases.%20BMI%2C%20VAT%2C%20SAT%2C%20and%20WC%20were%20correlated%20with%20the%20severity%20of%20acute%20pancreatitis%20in%20a%20univariate%20analysis%2C%20but%20only%20VAT%20had%20a%20strong%20correlation%20with%20severe%20acute%20pancreatitis%20in%20the%20multivariate%20analysis.%20In%20a%20trend%20analysis%2C%20not%20only%20severity%20but%20also%20the%20presence%20of%20pseudocysts%20%28local%20complication%29%20and%20prognostic%20factors%20%28Ranson%20and%20APACHE%20II%20scores%29%20were%20significantly%20related%20to%20VAT%20volume.%20In%20particular%2C%20the%20presence%20of%20a%20pancreatic%20pseudocyst%20was%20strongly%20related%20to%20VAT%20volume%20%28p%5Cu00a0%3C%5Cu00a00.001%29.%5CnCONCLUSION%3A%20In%20acute%20pancreatitis%2C%20peripancreatic%20VAT%20has%20a%20stronger%20correlation%20with%20severe%20acute%20pancreatitis%20than%20BMI%20or%20WC.%20VAT%20volume%20is%20strongly%20correlated%20with%20the%20formation%20of%20a%20pseudocyst%20and%20with%20systemic%20inflammatory%20response%20syndrome%20in%20patients%20with%20acute%20pancreatitis%20and%20high%20VAT%20volume%20may%20lead%20to%20severe%20acute%20pancreatitis.%22%2C%22date%22%3A%22Oct%202011%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs00535-011-0430-x%22%2C%22ISSN%22%3A%221435-5922%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-22T01%3A07%3A11Z%22%7D%7D%2C%7B%22key%22%3A%22CCK8RRFB%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Donigan%20et%20al.%22%2C%22parsedDate%22%3A%222010-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDonigan%2C%20M.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20A%20metastatic%20colon%20cancer%20model%20using%20nonoperative%20transanal%20rectal%20injection.%20%3Ci%3ESurg%20Endosc%3C%5C%2Fi%3E%20%3Cb%3E24%3C%5C%2Fb%3E%2C%20642%26%23x2013%3B647%20%282010%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20metastatic%20colon%20cancer%20model%20using%20nonoperative%20transanal%20rectal%20injection%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%22%2C%22lastName%22%3A%22Donigan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20D.%22%2C%22lastName%22%3A%22Loh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurie%20S.%22%2C%22lastName%22%3A%22Norcross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shuan%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20R.%22%2C%22lastName%22%3A%22Williamson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%22%2C%22lastName%22%3A%22DeJesus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%22%2C%22lastName%22%3A%22Ferrara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20T.%22%2C%22lastName%22%3A%22Gallagher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cheryl%20H.%22%2C%22lastName%22%3A%22Baker%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20This%20study%20aimed%20to%20develop%20a%20noninvasive%20orthotopic%20model%20for%20metastasis%20of%20colon%20and%20rectal%20cancer%20using%20a%20transanal%20approach.%20Currently%2C%20the%20most%20accurate%20orthotopic%20representation%20of%20metastatic%20human%20colon%20cancer%20is%20via%20a%20cecal%20injection.%20The%20transanal%20model%20allows%20for%20further%20examination%20of%20systemic%20immune%20responses%2C%20tumor%20take%2C%20and%20onset%20of%20metastasis%20without%20prior%20surgical%20intervention.%5CnMETHODS%3A%20For%20this%20study%2C%2060%20Balb%5C%2Fc%20mice%20were%20anesthetized%20and%20subjected%20to%20gentle%20anal%20dilation%20using%20blunt-tipped%20forceps%20at%20the%20anal%20opening.%20Murine%20colon%20cancer%20parental%20CT26%20or%20luciferase-labeled%20CT26%20%28CT26-luc%29%20cells%20were%20injected%20submucosally%20into%20the%20distal%20posterior%20rectum%20%2830%20CT26%20and%2030%20CT26%20injections%29%20at%20concentrations%20of%202.5%20x%2010%284%29%2C%201%20x%2010%285%29%2C%20and%201%20x%2010%286%29%20in%20a%20volume%20of%2050%20microl.%20Tumor%20growth%20and%20metastatic%20development%20was%20monitored%20at%205-day%20intervals%20for%2050%20days.%20All%20the%20remaining%20mice%20were%20killed%20on%20postinjection%20day%2050.%5CnRESULTS%3A%20The%20optimal%20concentration%20for%20metastasis%20and%20survival%20of%20the%20mice%20was%202.5%20x%2010%284%29%20cells.%20Higher%20concentrations%20of%20cells%20yielded%20higher%20mortality%20but%20did%20not%20result%20in%20metastasis.%20The%20overall%20success%20of%20tumor%20growth%20in%20both%20experiments%20using%20the%20transanal%20rectal%20injection%20was%2065%25.%20Histology%20showed%20that%20all%20tumors%20were%20poorly%20differentiated%20adenocarcinomas.%20Two%20mice%20%283.3%25%29%20from%20the%202.5%20x%2010%284%29%20CT26-luc%20group%20showed%20metastatic%20colonic%20adenocarcinoma%20to%20the%20liver%20on%20postinjection%20day%2050.%5CnCONCLUSION%3A%20Transanal%20rectal%20injection%20of%20colon%20cancer%20cells%20offers%20a%20nonoperative%20orthotopic%20murine%20model%20for%20colon%20cancer%20that%20may%20lead%20to%20the%20development%20of%20metastasis.%20By%20using%20an%20orthotopic%20model%2C%20more%20aspects%20of%20metastatic%20colon%20cancer%20can%20be%20evaluated%20without%20the%20influence%20of%20a%20previous%20abdominal%20incision.%20These%20results%20warrant%20more%20investigation.%22%2C%22date%22%3A%22Mar%202010%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs00464-009-0650-9%22%2C%22ISSN%22%3A%221432-2218%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%222FN43GFN%22%5D%2C%22dateModified%22%3A%222019-08-20T15%3A06%3A37Z%22%7D%7D%2C%7B%22key%22%3A%22PYYATP22%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Turker%20et%20al.%22%2C%22parsedDate%22%3A%222014-07-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ETurker%2C%20N.%20S.%2C%20Heidari%2C%20P.%2C%20Kucherlapati%2C%20R.%2C%20Kucherlapati%2C%20M.%20%26amp%3B%20Mahmood%2C%20U.%20An%20EGFR%20Targeted%20PET%20Imaging%20Probe%20for%20the%20Detection%20of%20Colonic%20Adenocarcinomas%20in%20the%20Setting%20of%20Colitis.%20%3Ci%3ETheranostics%3C%5C%2Fi%3E%20%3Cb%3E4%3C%5C%2Fb%3E%2C%20893%26%23x2013%3B903%20%282014%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22An%20EGFR%20Targeted%20PET%20Imaging%20Probe%20for%20the%20Detection%20of%20Colonic%20Adenocarcinomas%20in%20the%20Setting%20of%20Colitis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%20Selcan%22%2C%22lastName%22%3A%22Turker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pedram%22%2C%22lastName%22%3A%22Heidari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raju%22%2C%22lastName%22%3A%22Kucherlapati%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melanie%22%2C%22lastName%22%3A%22Kucherlapati%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Umar%22%2C%22lastName%22%3A%22Mahmood%22%7D%5D%2C%22abstractNote%22%3A%22Colorectal%20cancer%20is%20a%20serious%20complication%20associated%20with%20inflammatory%20bowel%20disease%2C%20often%20indistinguishable%20by%20screening%20with%20conventional%20FDG%20PET%20probes.%20We%20have%20developed%20an%20alternative%20EGFR-targeted%20PET%20imaging%20probe%20that%20may%20be%20used%20to%20overcome%20this%20difficulty%2C%20and%20successfully%20assessed%20its%20utility%20for%20neoplastic%20lesion%20detection%20in%20preclinical%20models.%20Cetuximab%20F%28ab%5Cu2032%292%20fragments%20were%20enzymatically%20generated%2C%20purified%2C%20and%20DOTA-conjugated.%20Radiolabeling%20was%20performed%20with%2067Ga%20for%20cell%20based%20studies%20and%2064Cu%20for%20in%20vivo%20imaging.%20Competitive%20binding%20studies%20were%20performed%20on%20CT26%20cells%20to%20assess%20affinity%20%28KD%29%20and%20receptors%20per%20cell%20%28Bmax%29.%20In%20vivo%20imaging%20using%20the%20EGFR%20targeted%20PET%20probe%20and%2018F%20FDG%20was%20performed%20on%20CT26%20tumor%20bearing%20mice%20in%20both%20control%20and%20dextran%20sodium%20sulfate%20%28DSS%29%20induced%20colitis%20settings.%20Spontaneous%20adenomas%20in%20genetically%20engineered%20mouse%20%28GEM%29%20models%20of%20colon%20cancer%20were%20additionally%20imaged.%20The%20EGFR%20imaging%20agent%20was%20generated%20with%20high%20purity%20%28%3E%2098%25%29%2C%20with%20a%20labeling%20efficiency%20of%2060%20%5Cu00b1%205%25%20and%20%5Cu226599%25%20radiochemical%20purity.%20The%20KD%20was%206.6%20%5Cu00b1%200.7%20nM%20and%20the%20Bmax%20for%20CT26%20cells%20was%203.3%20%5Cu00b1%200.1%20%5Cu00d7%20106%20receptors%5C%2Fcell.%20Target%20to%20background%20ratios%20%28TBR%29%20for%20CT26%20tumors%20compared%20to%20colonic%20uptake%20demonstrated%20high%20values%20for%20both%2018F-FDG%20%283.95%20%5Cu00b1%200.13%29%20and%20the%20developed%2064Cu-DOTA-cetuximab-F%28ab%5Cu2032%292%20probe%20%284.42%20%5Cu00b1%200.11%29%20in%20control%20mice.%20The%20TBR%20for%20the%20EGFR%20targeted%20probe%20remained%20high%20%283.78%20%5Cu00b1%200.06%29%20in%20the%20setting%20of%20colitis%2C%20while%20for%2018F%20FDG%2C%20this%20was%20markedly%20reduced%20%281.54%20%5Cu00b1%200.08%29.%20Assessment%20of%20the%20EGFR%20targeted%20probe%20in%20the%20GEM%20models%20demonstrated%20a%20correlation%20between%20radiotracer%20uptake%20in%20spontaneous%20colonic%20lesions%20and%20the%20EGFR%20staining%20level%20ex%20vivo.%20A%20clinically%20translatable%20PET%20imaging%20probe%20was%20successfully%20developed%20to%20assess%20EGFR.%20The%20imaging%20agent%20can%20detect%20colonic%20tumors%20with%20a%20high%20TBR%20for%20detection%20of%20in%20situ%20lesions%20in%20the%20setting%20of%20colitis%2C%20and%20opens%20the%20possibility%20for%20a%20new%20approach%20for%20screening%20high-risk%20patients.%22%2C%22date%22%3A%222014-7-1%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.7150%5C%2Fthno.9425%22%2C%22ISSN%22%3A%221838-7640%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4107290%5C%2F%22%2C%22collections%22%3A%5B%222FN43GFN%22%5D%2C%22dateModified%22%3A%222019-08-20T13%3A43%3A55Z%22%7D%7D%2C%7B%22key%22%3A%22YT7LTH3D%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zhao%20et%20al.%22%2C%22parsedDate%22%3A%222017-06-09%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EZhao%2C%20X.%2C%20Li%2C%20L.%2C%20Starr%2C%20T.%20K.%20%26amp%3B%20Subramanian%2C%20S.%20Tumor%20location%20impacts%20immune%20response%20in%20mouse%20models%20of%20colon%20cancer.%20%3Ci%3EOncotarget%3C%5C%2Fi%3E%20%3Cb%3E8%3C%5C%2Fb%3E%2C%2054775%26%23x2013%3B54787%20%282017%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Tumor%20location%20impacts%20immune%20response%20in%20mouse%20models%20of%20colon%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xianda%22%2C%22lastName%22%3A%22Zhao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lihua%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20K.%22%2C%22lastName%22%3A%22Starr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Subbaya%22%2C%22lastName%22%3A%22Subramanian%22%7D%5D%2C%22abstractNote%22%3A%22Existing%20preclinical%20models%20of%20human%20colorectal%20cancer%20%28CRC%29%20that%20rely%20on%20syngeneic%20subcutaneous%20grafts%20are%20problematic%2C%20because%20of%20increasing%20evidence%20that%20the%20immune%20microenvironment%20in%20subcutaneous%20tissue%20is%20significantly%20different%20from%20the%20gastrointestinal%20tract.%20Similarly%2C%20existing%20orthotopic%20models%20that%20use%20a%20laparotomy%20for%20establishing%20grafts%20are%20also%20problematic%2C%20because%20the%20surgical%20procedure%20results%20in%20extensive%20inflammation%2C%20thereby%20creating%20a%20nonphysiologic%20tumor%20microenvironment.%20To%20facilitate%20the%20bench-to-bedside%20translation%20of%20CRC%20immunotherapy%20strategies%2C%20we%20developed%20a%20novel%20orthotopic%20model%20in%20mice%20that%20uses%20endoscopy-guided%20microinjection%20of%20syngeneic%20cancer%20cells.%20When%20we%20compared%20immune%20system%20infiltration%2C%20we%20found%20that%20tumors%20in%20the%20subcutaneous%20model%20had%20fewer%20T%20cells%2C%20B%20cells%2C%20and%20natural%20killer%20%28NK%29%20cells%2C%20but%20more%20immunosuppressive%20myeloid%20cells%3B%20in%20contrast%2C%20tumors%20in%20our%20orthotopic%20model%20had%20a%20higher%20number%20of%20tumor-infiltrating%20T%20cells%2C%20B%20cells%2C%20and%20NK%20cells%2C%20with%20fewer%20immunosuppressive%20myeloid%20cells.%20The%20number%20of%20immune-stimulating%20cytokines%2C%20such%20as%20interleukin%20%28IL%29-2%2C%20IL-6%2C%20interferon%20%28IFN%29-gamma%2C%20and%20granzyme%20B%2C%20was%20also%20higher%20in%20tumors%20in%20our%20model%2C%20as%20compared%20with%20the%20subcutaneous%20model.%20Those%20differences%20resulted%20in%20heightened%20sensitivity%20to%20immune%20checkpoint%20blockade%20therapy%20in%20our%20endoscopy-guided%20orthotopic%20CRC%20model.%20Our%20study%20indicates%20that%20tumor%20location%20affects%20immune%20response%20in%20CRC%20mouse%20models%3B%20choosing%20the%20appropriate%20preclinical%20model%20is%20important%20when%20testing%20immunotherapy%20in%20CRC.%22%2C%22date%22%3A%222017-6-9%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.18632%5C%2Foncotarget.18423%22%2C%22ISSN%22%3A%221949-2553%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5589620%5C%2F%22%2C%22collections%22%3A%5B%222FN43GFN%22%5D%2C%22dateModified%22%3A%222019-08-20T13%3A42%3A01Z%22%7D%7D%2C%7B%22key%22%3A%224JXNNZ7D%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Forsmark%20et%20al.%22%2C%22parsedDate%22%3A%222018-12%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EForsmark%2C%20C.%20E.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20Accelerating%20the%20Drug%20Delivery%20Pipeline%20for%20Acute%20and%20Chronic%20Pancreatitis%3A%20Summary%20of%20the%20Working%20Group%20on%20Drug%20Development%20and%20Trials%20in%20Chronic%20Pancreatitis%20at%20the%20National%20Institute%20of%20Diabetes%20and%20Digestive%20and%20Kidney%20Diseases%20Workshop.%20%3Ci%3EPancreas%3C%5C%2Fi%3E%20%3Cb%3E47%3C%5C%2Fb%3E%2C%201200%26%23x2013%3B1207%20%282018%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Accelerating%20the%20Drug%20Delivery%20Pipeline%20for%20Acute%20and%20Chronic%20Pancreatitis%3A%20Summary%20of%20the%20Working%20Group%20on%20Drug%20Development%20and%20Trials%20in%20Chronic%20Pancreatitis%20at%20the%20National%20Institute%20of%20Diabetes%20and%20Digestive%20and%20Kidney%20Diseases%20Workshop%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20E.%22%2C%22lastName%22%3A%22Forsmark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dana%20K.%22%2C%22lastName%22%3A%22Andersen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20T.%22%2C%22lastName%22%3A%22Farrar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megan%22%2C%22lastName%22%3A%22Golden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aida%22%2C%22lastName%22%3A%22Habtezion%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sohail%20Z.%22%2C%22lastName%22%3A%22Husain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liang%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%22%2C%22lastName%22%3A%22Mayerle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20J.%22%2C%22lastName%22%3A%22Pandol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aliye%22%2C%22lastName%22%3A%22Uc%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zixi%22%2C%22lastName%22%3A%22Zhu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dhiraj%22%2C%22lastName%22%3A%22Yadav%22%7D%5D%2C%22abstractNote%22%3A%22The%20lack%20of%20effective%20therapeutic%20agents%20specifically%20tailored%20for%20chronic%20pancreatitis%20%28CP%29%20has%20hampered%20clinical%20care%20and%20negatively%20impacted%20patients%27%20lives.%20New%20mechanistic%20insights%20now%20point%20to%20novel%20therapies%2C%20which%20involve%20both%20recently%20developed%20and%5C%2For%20repurposed%20agents.%20This%20working%20group%20focused%20on%202%20main%20outcomes%20for%20CP%3A%20pain%20and%20progression%20of%20disease.%20The%20goal%20is%20to%20frame%20the%20essential%20aspects%20of%20trial%20design%20including%20patient-centered%20outcomes%2C%20proposed%20methods%20to%20measure%20the%20outcomes%20of%20pain%20and%20progression%2C%20and%20study%20design%20considerations%20for%20future%20trials%20to%20facilitate%20rapid%20drug%20development%20for%20patients%20with%20CP.%22%2C%22date%22%3A%222018%20Nov%5C%2FDec%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FMPA.0000000000001174%22%2C%22ISSN%22%3A%221536-4828%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-16T12%3A47%3A33Z%22%7D%7D%2C%7B%22key%22%3A%22RMNXQ8IJ%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Abu-El-Haija%20et%20al.%22%2C%22parsedDate%22%3A%222018-12%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAbu-El-Haija%2C%20M.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20Accelerating%20the%20Drug%20Delivery%20Pipeline%20for%20Acute%20and%20Chronic%20Pancreatitis%3A%20Summary%20of%20the%20Working%20Group%20on%20Drug%20Development%20and%20Trials%20in%20Acute%20Pancreatitis%20at%20the%20National%20Institute%20of%20Diabetes%20and%20Digestive%20and%20Kidney%20Diseases%20Workshop.%20%3Ci%3EPancreas%3C%5C%2Fi%3E%20%3Cb%3E47%3C%5C%2Fb%3E%2C%201185%26%23x2013%3B1192%20%282018%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Accelerating%20the%20Drug%20Delivery%20Pipeline%20for%20Acute%20and%20Chronic%20Pancreatitis%3A%20Summary%20of%20the%20Working%20Group%20on%20Drug%20Development%20and%20Trials%20in%20Acute%20Pancreatitis%20at%20the%20National%20Institute%20of%20Diabetes%20and%20Digestive%20and%20Kidney%20Diseases%20Workshop%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maisam%22%2C%22lastName%22%3A%22Abu-El-Haija%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20S.%22%2C%22lastName%22%3A%22Gukovskaya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dana%20K.%22%2C%22lastName%22%3A%22Andersen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20B.%22%2C%22lastName%22%3A%22Gardner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Hegyi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20J.%22%2C%22lastName%22%3A%22Pandol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Georgios%20I.%22%2C%22lastName%22%3A%22Papachristou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ashok%20K.%22%2C%22lastName%22%3A%22Saluja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vikesh%20K.%22%2C%22lastName%22%3A%22Singh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aliye%22%2C%22lastName%22%3A%22Uc%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bechien%20U.%22%2C%22lastName%22%3A%22Wu%22%7D%5D%2C%22abstractNote%22%3A%22A%20workshop%20was%20sponsored%20by%20the%20National%20Institute%20of%20Diabetes%20and%20Digestive%20and%20Kidney%20Diseases%20to%20focus%20on%20research%20gaps%20and%20opportunities%20on%20drug%20development%20for%20pancreatitis.%20This%20conference%20was%20held%20on%20July%2025%2C%202018%2C%20and%20structured%20into%203%20working%20groups%20%28WG%29%3A%20acute%20pancreatitis%20%28AP%29%20WG%2C%20recurrent%20AP%20WG%2C%20and%20chronic%20pancreatitis%20WG.%20This%20article%20reports%20the%20outcome%20of%20the%20work%20accomplished%20by%20the%20AP%20WG%20to%20provide%20the%20natural%20history%2C%20epidemiology%2C%20and%20current%20management%20of%20AP%3B%20inform%20about%20the%20role%20of%20preclinical%20models%20in%20therapy%20selection%3B%20and%20discuss%20clinical%20trial%20designs%20with%20clinical%20and%20patient-reported%20outcomes%20to%20test%20new%20therapies.%22%2C%22date%22%3A%222018%20Nov%5C%2FDec%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FMPA.0000000000001175%22%2C%22ISSN%22%3A%221536-4828%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-16T12%3A47%3A02Z%22%7D%7D%2C%7B%22key%22%3A%22TJL5XPH7%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Uc%20et%20al.%22%2C%22parsedDate%22%3A%222018-12%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EUc%2C%20A.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20Accelerating%20the%20Drug%20Delivery%20Pipeline%20for%20Acute%20and%20Chronic%20Pancreatitis-Knowledge%20Gaps%20and%20Research%20Opportunities%3A%20Overview%20Summary%20of%20a%20National%20Institute%20of%20Diabetes%20and%20Digestive%20and%20Kidney%20Diseases%20Workshop.%20%3Ci%3EPancreas%3C%5C%2Fi%3E%20%3Cb%3E47%3C%5C%2Fb%3E%2C%201180%26%23x2013%3B1184%20%282018%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Accelerating%20the%20Drug%20Delivery%20Pipeline%20for%20Acute%20and%20Chronic%20Pancreatitis-Knowledge%20Gaps%20and%20Research%20Opportunities%3A%20Overview%20Summary%20of%20a%20National%20Institute%20of%20Diabetes%20and%20Digestive%20and%20Kidney%20Diseases%20Workshop%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aliye%22%2C%22lastName%22%3A%22Uc%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dana%20K.%22%2C%22lastName%22%3A%22Andersen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Drucy%22%2C%22lastName%22%3A%22Borowitz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marshall%20J.%22%2C%22lastName%22%3A%22Glesby%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%22%2C%22lastName%22%3A%22Mayerle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Sutton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20J.%22%2C%22lastName%22%3A%22Pandol%22%7D%5D%2C%22abstractNote%22%3A%22A%20workshop%20was%20sponsored%20by%20the%20Division%20of%20Digestive%20Diseases%20and%20Nutrition%2C%20National%20Institute%20of%20Diabetes%20and%20Digestive%20and%20Kidney%20Diseases%2C%20National%20Institutes%20of%20Health%2C%20on%20July%2025%2C%202018%2C%20in%20Pittsburgh%2C%20Penn.%20The%20workshop%20was%20designed%20to%20bring%20together%20a%20multidisciplinary%20group%20of%20experts%20to%20accelerate%20the%20development%20of%20therapeutics%20for%20clinical%20application%20in%20inflammatory%20diseases%20of%20the%20exocrine%20pancreas.%20Three%20separate%20working%20groups%20%28acute%20pancreatitis%2C%20recurrent%20acute%20pancreatitis%2C%20and%20chronic%20pancreatitis%29%20were%20formed%20to%20address%20the%20needs%2C%20gaps%2C%20and%20opportunities.%20The%20working%20groups%20included%20patients%20with%20pancreatic%20diseases%2C%20pharmaceutical%20company%20leaders%2C%20basic%20scientists%2C%20clinical%20researchers%2C%20and%20representatives%20from%20the%20US%20Food%20and%20Drug%20Administration%20to%20assist%20with%20regulatory%20considerations%20and%20to%20identify%20the%20unmet%20needs%2C%20research%20targets%2C%20and%20opportunities%20to%20provide%20direction%20for%20successful%20development%20of%20therapeutic%20agents%20in%20these%20diseases.%20This%20article%20represents%20the%20summary%20of%20the%20overview%20presentations%20at%20the%20National%20Institute%20of%20Diabetes%20and%20Digestive%20and%20Kidney%20Diseases%20workshop%20including%20an%20ongoing%20drug%20trial%20in%20acute%20pancreatitis%3B%20a%20successful%20drug%20development%20network%20developed%20by%20the%20Cystic%20Fibrosis%20Foundation%3B%20and%20considerations%20for%20subject%20selection%20in%20drug%20trials%2C%20incorporating%20Food%20and%20Drug%20Administration%20guidelines%20on%20clinical%20trial%20design%20and%20clinical%20outcome%20measures.%20The%20summaries%20of%20each%20working%20group%20follow%20separately%20in%20accompanying%20articles.%22%2C%22date%22%3A%222018%20Nov%5C%2FDec%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FMPA.0000000000001176%22%2C%22ISSN%22%3A%221536-4828%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-16T12%3A46%3A43Z%22%7D%7D%2C%7B%22key%22%3A%22MDFINLF8%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sennello%20et%20al.%22%2C%22parsedDate%22%3A%222008-06-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESennello%2C%20J.%20A.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20Interleukin-18%2C%20together%20with%20interleukin-12%2C%20induces%20severe%20acute%20pancreatitis%20in%20obese%20but%20not%20in%20nonobese%20leptin-deficient%20mice.%20%3Ci%3EProc%20Natl%20Acad%20Sci%20U%20S%20A%3C%5C%2Fi%3E%20%3Cb%3E105%3C%5C%2Fb%3E%2C%208085%26%23x2013%3B8090%20%282008%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Interleukin-18%2C%20together%20with%20interleukin-12%2C%20induces%20severe%20acute%20pancreatitis%20in%20obese%20but%20not%20in%20nonobese%20leptin-deficient%20mice%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20A.%22%2C%22lastName%22%3A%22Sennello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raja%22%2C%22lastName%22%3A%22Fayad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%22%2C%22lastName%22%3A%22Pini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%20E.%22%2C%22lastName%22%3A%22Gove%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Venkatesh%22%2C%22lastName%22%3A%22Ponemone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20J.%22%2C%22lastName%22%3A%22Cabay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Britta%22%2C%22lastName%22%3A%22Siegmund%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20A.%22%2C%22lastName%22%3A%22Dinarello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giamila%22%2C%22lastName%22%3A%22Fantuzzi%22%7D%5D%2C%22abstractNote%22%3A%22Obesity%20is%20associated%20with%20increased%20severity%20of%20acute%20pancreatitis%20%28AP%29.%20The%20cytokines%20IL-18%20and%20IL-12%20are%20elevated%20in%20patients%20with%20AP%2C%20and%20IL-18%20levels%20are%20high%20in%20obesity.%20We%20aimed%20to%20develop%20a%20pathologically%20relevant%20model%20to%20study%20obesity-associated%20severe%20AP.%20Lean%20WT%20and%20obese%20leptin-deficient%20ob%5C%2Fob%20mice%20received%20two%20injections%20of%20IL-12%20plus%20IL-18.%20Survival%2C%20pancreatic%20inflammation%2C%20and%20biochemical%20markers%20of%20AP%20were%20measured.%20Dosing%20with%20IL-12%20plus%20IL-18%20induced%20100%25%20lethality%20in%20ob%5C%2Fob%20mice%3B%20no%20lethality%20was%20observed%20in%20WT%20mice.%20Disruption%20of%20pancreatic%20exocrine%20tissue%20and%20acinar%20cell%20death%20as%20well%20as%20serum%20amylase%20and%20lipase%20levels%20were%20significantly%20higher%20in%20ob%5C%2Fob%20than%20in%20WT%20mice.%20Edematous%20AP%20developed%20in%20WT%20mice%2C%20whereas%20obese%20ob%5C%2Fob%20mice%20developed%20necrotizing%20AP.%20Adipose%20tissue%20necrosis%20and%20saponification%20were%20present%20in%20cytokine-injected%20ob%5C%2Fob%20but%20not%20in%20WT%20mice.%20Severe%20hypocalcemia%20and%20elevated%20acute-phase%20response%20developed%20in%20ob%5C%2Fob%20mice.%20The%20cytokine%20combination%20induced%20high%20levels%20of%20regenerating%20protein%201%20and%20pancreatitis-associated%20protein%20expression%20in%20the%20pancreas%20of%20WT%20but%20not%20of%20ob%5C%2Fob%20mice.%20To%20differentiate%20the%20contribution%20of%20obesity%20to%20that%20of%20leptin%20deficiency%2C%20mice%20received%20short-%20and%20long-term%20leptin%20replacement%20therapy.%20Short-term%20leptin%20reconstitution%20in%20the%20absence%20of%20major%20weight%20loss%20did%20not%20protect%20ob%5C%2Fob%20mice%2C%20whereas%20leptin%20deficiency%20in%20the%20absence%20of%20obesity%20resulted%20in%20a%20significant%20reduction%20in%20the%20severity%20of%20the%20pancreatitis.%20In%20conclusion%2C%20we%20developed%20a%20pathologically%20relevant%20model%20of%20AP%20in%20which%20obesity%20per%20se%20is%20associated%20with%20increased%20severity.%22%2C%22date%22%3A%222008-6-10%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1073%5C%2Fpnas.0804091105%22%2C%22ISSN%22%3A%220027-8424%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC2430363%5C%2F%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-14T20%3A51%3A05Z%22%7D%7D%2C%7B%22key%22%3A%22XB2SGGS5%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Anandan%20et%20al.%22%2C%22parsedDate%22%3A%222019-01-17%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAnandan%2C%20S.-K.%2C%20GREENMAN%2C%20K.%2C%20KAMAL%2C%20Z.%20%26amp%3B%20Singh%2C%20V.%20P.%20Compounds%20for%20the%20reducing%20lipotoxic%20damage.%20%282019%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22patent%22%2C%22title%22%3A%22Compounds%20for%20the%20reducing%20lipotoxic%20damage%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22inventor%22%2C%22firstName%22%3A%22Sampath-Kumar%22%2C%22lastName%22%3A%22Anandan%22%7D%2C%7B%22creatorType%22%3A%22inventor%22%2C%22firstName%22%3A%22Kevin%22%2C%22lastName%22%3A%22GREENMAN%22%7D%2C%7B%22creatorType%22%3A%22inventor%22%2C%22firstName%22%3A%22Zeeshan%22%2C%22lastName%22%3A%22KAMAL%22%7D%2C%7B%22creatorType%22%3A%22inventor%22%2C%22firstName%22%3A%22Vijay%20P.%22%2C%22lastName%22%3A%22Singh%22%7D%5D%2C%22abstractNote%22%3A%22Provided%20herein%20are%20novel%20lipase%20inhibitors%20and%20methods%20for%20using%20the%20same%20to%20treat%20inflammation%2C%20multisystem%20organ%20failure%2C%20necrotic%20pancreatic%20acinar%20cell%20death%2C%20acute%20pancreatitis%2C%20sepsis%20%28e.g.%2C%20culture%20negative%20sepsis%29%2C%20burns%2C%20and%20acne.%20For%20example%2C%20provided%20herein%20are%20two%20novel%20lipase%20inhibitors%20useful%20in%20the%20methods%20described%20herein%3A%20%28I%29%20%28II%29%20or%20a%20pharmaceutically%20acceptable%20salt%20thereof.%22%2C%22country%22%3A%22WO%22%2C%22assignee%22%3A%22Mayo%20Foundation%20For%20Medical%20Education%20And%20Research%22%2C%22issuingAuthority%22%3A%22World%20Intellectual%20Property%20Organization%22%2C%22patentNumber%22%3A%22WO2019014434A1%22%2C%22filingDate%22%3A%222018-07-12%202018-07-12%22%2C%22applicationNumber%22%3A%22PCT%5C%2FUS2018%5C%2F041796%22%2C%22priorityNumbers%22%3A%22%22%2C%22issueDate%22%3A%222019-01-17%22%2C%22references%22%3A%22%22%2C%22legalStatus%22%3A%22%22%2C%22language%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fpatents.google.com%5C%2Fpatent%5C%2FWO2019014434A1%5C%2Fen%5C%2F%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-14T16%3A08%3A45Z%22%7D%7D%2C%7B%22key%22%3A%22K65PW9WG%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ismail%20and%20Bhayana%22%2C%22parsedDate%22%3A%222017-12%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EIsmail%2C%20O.%20Z.%20%26amp%3B%20Bhayana%2C%20V.%20Lipase%20or%20amylase%20for%20the%20diagnosis%20of%20acute%20pancreatitis%3F%20%3Ci%3EClin.%20Biochem.%3C%5C%2Fi%3E%20%3Cb%3E50%3C%5C%2Fb%3E%2C%201275%26%23x2013%3B1280%20%282017%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Lipase%20or%20amylase%20for%20the%20diagnosis%20of%20acute%20pancreatitis%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ola%20Z.%22%2C%22lastName%22%3A%22Ismail%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vipin%22%2C%22lastName%22%3A%22Bhayana%22%7D%5D%2C%22abstractNote%22%3A%22Acute%20pancreatitis%20is%20a%20rapid%20onset%20of%20inflammation%20of%20the%20pancreas%20causing%20mild%20to%20severe%20life%20threatening%20conditions%20%5B1%2C%202%5D.%20In%20Canada%2C%20acute%20pancreatitis%20is%20the%205th%20most%20expensive%20digestive%20disease%20in%20Canada%20with%20a%20considerable%20economic%20burden%20on%20the%20health%20care%20system%20%5B3%5D.%20The%20diagnosis%20of%20acute%20pancreatitis%20is%20usually%20based%20on%20the%20presence%20of%20abdominal%20pain%20and%20elevated%20levels%20of%20serum%20amylase%20and%5C%2For%20lipase.%20Many%20health%20care%20centers%20use%20either%20serum%20amylase%2C%20lipase%20or%20both%20to%20diagnose%20acute%20pancreatitis%20without%20considering%20which%20one%20could%20provide%20a%20better%20diagnostic%20accuracy.%20The%20aim%20of%20this%20review%20is%20to%20investigate%20whether%20serum%20lipase%20alone%20is%20a%20sufficient%20biomarker%20for%20the%20diagnosis%20of%20acute%20pancreatitis.%20We%20have%20examined%20various%20studies%20looking%20at%20the%20utilization%2C%20sensitivity%2C%20specificity%20and%20cost%20associated%20savings%20of%20lipase%20and%20amylase%20in%20the%20diagnosis%20of%20acute%20pancreatitis.%20When%20comparing%20different%20studies%2C%20serum%20lipase%20offers%20a%20higher%20sensitivity%20than%20serum%20amylase%20in%20diagnosing%20acute%20pancreatitis.%20Lipase%20also%20offers%20a%20larger%20diagnostic%20window%20than%20amylase%20since%20it%20is%20elevated%20for%20a%20longer%20time%2C%20thus%20allowing%20it%20to%20be%20a%20useful%20diagnostic%20biomarker%20in%20early%20and%20late%20stages%20of%20acute%20pancreatitis.%20Several%20recent%20evidence-based%20guidelines%20recommend%20the%20use%20of%20lipase%20over%20amylase.%20Nevertheless%2C%20both%20lipase%20and%20amylase%20alone%20lack%20the%20ability%20to%20determine%20the%20severity%20and%20etiology%20of%20acute%20pancreatitis.%20The%20co-ordering%20of%20both%20tests%20has%20shown%20little%20to%20no%20increase%20in%20the%20diagnostic%20sensitivity%20and%20specificity.%20Thus%2C%20unnecessary%20testing%20and%20laboratory%20expenditures%20can%20be%20reduced%20by%20testing%20lipase%20alone.%22%2C%22date%22%3A%22Dec%202017%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.clinbiochem.2017.07.003%22%2C%22ISSN%22%3A%221873-2933%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-14T14%3A32%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22Z33Q6H5B%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Thiruvengadam%20et%20al.%22%2C%22parsedDate%22%3A%222016-08-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EThiruvengadam%2C%20N.%20R.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20Rectal%20Indomethacin%20Reduces%20Pancreatitis%20in%20High-%20and%20Low-Risk%20Patients%20Undergoing%20Endoscopic%20Retrograde%20Cholangiopancreatography.%20%3Ci%3EGastroenterology%3C%5C%2Fi%3E%20%3Cb%3E151%3C%5C%2Fb%3E%2C%20288-297.e4%20%282016%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Rectal%20Indomethacin%20Reduces%20Pancreatitis%20in%20High-%20and%20Low-Risk%20Patients%20Undergoing%20Endoscopic%20Retrograde%20Cholangiopancreatography%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nikhil%20R.%22%2C%22lastName%22%3A%22Thiruvengadam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kimberly%20A.%22%2C%22lastName%22%3A%22Forde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gene%20K.%22%2C%22lastName%22%3A%22Ma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nuzhat%22%2C%22lastName%22%3A%22Ahmad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vinay%22%2C%22lastName%22%3A%22Chandrasekhara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%20G.%22%2C%22lastName%22%3A%22Ginsberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Immanuel%20K.%22%2C%22lastName%22%3A%22Ho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Jaffe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kashyap%20V.%22%2C%22lastName%22%3A%22Panganamamula%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20L.%22%2C%22lastName%22%3A%22Kochman%22%7D%5D%2C%22abstractNote%22%3A%22Background%20%26%20Aims%5CnRectal%20indomethacin%20reduces%20the%20risk%5Cu00a0of%20pancreatitis%20after%20endoscopic%20retrograde%20cholangiopancreatography%20%28ERCP%29.%20Most%20studies%20of%20its%20efficacy%20included%20high-risk%20cohorts%20and%20excluded%20low-risk%20patients%2C%20including%20those%20with%20malignant%20biliary%20obstruction.%20We%20investigated%20the%20potential%20of%20rectal%20indomethacin%20to%20prevent%20post-ERCP%20pancreatitis%20%28PEP%29%20in%20a%20variety%20of%20patients.%5CnMethods%5CnWe%20performed%20a%20retrospective%20cohort%20study%20of%204017%20patients%20who%20underwent%20ERCP%20at%20the%20Hospital%20of%20the%20University%20of%20Pennsylvania%2C%20from%202009%20and%202015%2C%20including%20823%20patients%20with%20malignant%20biliary%20obstruction.%20After%20June%202012%2C%20with%20a%20few%20exceptions%2C%20patients%20received%20indomethacin%20after%20their%20procedure.%20We%20collected%20data%20from%20patients%5Cu2019%20records%20on%20demographic%20and%20clinical%20features%2C%20procedures%2C%20and%20development%20of%20PEP.%20PEP%20was%20defined%20by%20consensus%20criteria.%20Multivariable%20logistic%20regression%20was%20used%20to%20determine%20adjusted%20odds%20ratios%20%28ORs%29%20for%20the%20association%20between%20indomethacin%20and%20PEP.%5CnResults%5CnRectal%20indomethacin%20reduced%20the%20odds%20of%20PEP%20by%2065%25%20%28OR%2C%200.35%3B%2095%25%20confidence%20interval%20%5BCI%5D%2C%200.24%5Cu20130.51%3B%20P%20%3C%20.001%29%20and%20moderate-to-severe%20PEP%20by%2083%25%20%28OR%2C%200.17%3B%2095%25%20CI%2C%200.09%5Cu20130.32%3B%20P%20%3C%20.001%29.%20In%20patients%20with%20malignant%20obstruction%2C%20rectal%20indomethacin%20reduced%20the%20risk%20of%20PEP%20by%2064%25%20%28OR%2C%200.36%3B%2095%25%20CI%2C%200.17%5Cu20130.75%3B%20P%5Cu00a0%3C%20.001%29%20and%20moderate-to-severe%20PEP%20by%2080%25%20%28OR%2C%200.20%3B%2095%25%20CI%2C%200.07%5Cu20130.63%3B%20P%20%3C%20.001%29.%20Among%20patients%20with%20malignant%20obstruction%2C%20rectal%20indomethacin%20provided%20the%20greatest%20benefit%20to%20patients%20with%20pancreatic%20adenocarcinoma%3A%202.31%25%20of%20these%20patients%20who%20received%20rectal%20indomethacin%20developed%20PEP%20vs%207.53%25%20who%20did%20not%20receive%20rectal%20indomethacin%20%28P%20%3C%20.001%29%20and%200.59%25%20of%20these%20patients%20who%20received%20rectal%20indomethacin%20developed%20moderate-to-severe%20PEP%20vs%204.32%25%20who%20did%20not%20receive%20rectal%20indomethacin%20%28P%5Cu00a0%3D%20.001%29.%5CnConclusions%5CnIn%20a%20large%20retrospective%20cohort%20study%20of%20patients%20undergoing%20ERCP%20that%20included%20low-risk%20patients%20and%20patients%20with%20malignant%20biliary%20obstruction%2C%20rectal%20indomethacin%20was%20associated%20with%20a%20significant%20decrease%20in%20the%20absolute%20rate%20and%20severity%20of%20pancreatitis.%22%2C%22date%22%3A%22August%201%2C%202016%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1053%5C%2Fj.gastro.2016.04.048%22%2C%22ISSN%22%3A%220016-5085%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0016508516344481%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-14T14%3A02%3A35Z%22%7D%7D%2C%7B%22key%22%3A%22IUE6YU68%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Song%20et%20al.%22%2C%22parsedDate%22%3A%222002-11-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESong%2C%20A.%20M.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20Inhibition%20of%20cyclooxygenase-2%20ameliorates%20the%26%23xA0%3B%20severity%20of%20pancreatitis%20and%20associated%20lung%20injury.%20%3Ci%3EAmerican%20Journal%20of%20Physiology-Gastrointestinal%20and%20Liver%20Physiology%3C%5C%2Fi%3E%20%3Cb%3E283%3C%5C%2Fb%3E%2C%20G1166%26%23x2013%3BG1174%20%282002%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Inhibition%20of%20cyclooxygenase-2%20ameliorates%20the%20%20severity%20of%20pancreatitis%20and%20associated%20lung%20injury%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%20M.%22%2C%22lastName%22%3A%22Song%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lakshmi%22%2C%22lastName%22%3A%22Bhagat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijay%20P.%22%2C%22lastName%22%3A%22Singh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gijs%20G.%20D.%22%2C%22lastName%22%3A%22Van%20Acker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20L.%22%2C%22lastName%22%3A%22Steer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ashok%20K.%22%2C%22lastName%22%3A%22Saluja%22%7D%5D%2C%22abstractNote%22%3A%22Cyclooxygenase-2%20%28COX-2%29%2C%20a%20widely%20distributed%20enzyme%2C%20plays%20an%20important%20role%20in%20inflammation.%20We%20have%20studied%20the%20role%20of%20COX-2%20in%20acute%20pancreatitis%20and%20pancreatitis-associated%20lung%20injury%20using%20both%20the%20pharmacological%20inhibition%20of%20COX-2%20and%20genetic%20deletion%20of%20COX-2.%20Pancreatitis%20was%20induced%20in%20mice%20by%2012%20hourly%20injections%20of%20cerulein.%20The%20severity%20of%20pancreatitis%20was%20assessed%20by%20measuring%20serum%20amylase%2C%20pancreatic%20trypsin%20activity%2C%20intrapancreatic%20sequestration%20of%20neutrophils%2C%20and%20acinar%20cell%20necrosis.%20The%20severity%20of%20lung%20injury%20was%20evaluated%20by%20measuring%20lactate%20dehydrogenase%20levels%20in%20the%20bronchoalveolar%20lavage%20fluid%20and%20by%20quantitating%20neutrophil%20sequestration%20in%20the%20lung.%20In%20both%20the%20pharmacologically%20inhibited%20and%20genetically%20altered%20mice%2C%20the%20severity%20of%20pancreatitis%20and%20pancreatitis-associated%20lung%20injury%20was%20reduced%20compared%20with%20the%20noninhibited%20strains%20of%20COX-2-sufficient%20mice.%20This%20reduction%20in%20injury%20indicates%20that%20COX-2%20plays%20an%20important%20proinflammatory%20role%20in%20pancreatitis%20and%20its%20associated%20lung%20injury.%20Our%20findings%20support%20the%20concept%20that%20COX-2%20inhibitors%20may%20play%20a%20beneficial%20role%20in%20the%20prevention%20of%20acute%20pancreatitis%20or%20in%20the%20reduction%20of%20its%20severity.%22%2C%22date%22%3A%22November%201%2C%202002%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1152%5C%2Fajpgi.00370.2001%22%2C%22ISSN%22%3A%220193-1857%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.physiology.org%5C%2Fdoi%5C%2Ffull%5C%2F10.1152%5C%2Fajpgi.00370.2001%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-14T14%3A02%3A11Z%22%7D%7D%2C%7B%22key%22%3A%22EYLGNDNP%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Patel%20et%20al.%22%2C%22parsedDate%22%3A%222015-03-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPatel%2C%20K.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20Lipolysis%20of%20Visceral%20Adipocyte%20Triglyceride%20by%20Pancreatic%20Lipases%20Converts%20Mild%20Acute%20Pancreatitis%20to%20Severe%20Pancreatitis%20Independent%20of%20Necrosis%20and%20Inflammation.%20%3Ci%3EThe%20American%20Journal%20of%20Pathology%3C%5C%2Fi%3E%20%3Cb%3E185%3C%5C%2Fb%3E%2C%20808%26%23x2013%3B819%20%282015%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Lipolysis%20of%20Visceral%20Adipocyte%20Triglyceride%20by%20Pancreatic%20Lipases%20Converts%20Mild%20Acute%20Pancreatitis%20to%20Severe%20Pancreatitis%20Independent%20of%20Necrosis%20and%20Inflammation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Krutika%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ram%20N.%22%2C%22lastName%22%3A%22Trivedi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chandra%22%2C%22lastName%22%3A%22Durgampudi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pawan%22%2C%22lastName%22%3A%22Noel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%20A.%22%2C%22lastName%22%3A%22Cline%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20P.%22%2C%22lastName%22%3A%22DeLany%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Navina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijay%20P.%22%2C%22lastName%22%3A%22Singh%22%7D%5D%2C%22abstractNote%22%3A%22Visceral%20fat%20necrosis%20has%20been%20associated%20with%20severe%20acute%20pancreatitis%20%28SAP%29%20for%20over%20100%20years%3B%20however%2C%20its%20pathogenesis%20and%20role%20in%20SAP%20outcomes%20are%20poorly%20understood.%20Based%20on%20recent%20work%20suggesting%20that%20pancreatic%20fat%20lipolysis%20plays%20an%20important%20role%20in%20SAP%2C%20we%20evaluated%20the%20role%20of%20pancreatic%20lipases%20in%20SAP-associated%20visceral%20fat%20necrosis%2C%20the%20inflammatory%20response%2C%20local%20injury%2C%20and%20outcomes%20of%20acute%20pancreatitis%20%28AP%29.%20For%20this%2C%20cerulein%20pancreatitis%20was%20induced%20in%20lean%20and%20obese%20mice%2C%20alone%20or%20with%20the%20lipase%20inhibitor%20orlistat%20and%20parameters%20of%20AP%20induction%20%28serum%20amylase%20and%20lipase%29%2C%20fat%20necrosis%2C%20pancreatic%20necrosis%2C%20and%20multisystem%20organ%20failure%2C%20and%20inflammatory%20response%20were%20assessed.%20Pancreatic%20lipases%20were%20measured%20in%20fat%20necrosis%20and%20were%20overexpressed%20in%203T3-L1%20cells.%20We%20noted%20obesity%20to%20convert%20mild%20cerulein%20AP%20to%20SAP%20with%20greater%20cytokines%2C%20unsaturated%20fatty%20acids%20%28UFAs%29%2C%20and%20multisystem%20organ%20failure%2C%20and%20100%25%20mortality%20without%20affecting%20AP%20induction%20or%20pancreatic%20necrosis.%20Increased%20pancreatic%20lipase%20amounts%20and%20activity%20were%20noted%20in%20the%20extensive%20visceral%20fat%20necrosis%20of%20dying%20obese%20mice.%20Lipase%20inhibition%20reduced%20fat%20necrosis%2C%20UFAs%2C%20organ%20failure%2C%20and%20mortality%20but%20not%20the%20parameters%20of%20AP%20induction.%20Pancreatic%20lipase%20expression%20increased%20lipolysis%20in%203T3-L1%20cells.%20We%20conclude%20that%20UFAs%20generated%20via%20lipolysis%20of%20visceral%20fat%20by%20pancreatic%20lipases%20convert%20mild%20AP%20to%20SAP%20independent%20of%20pancreatic%20necrosis%20and%20the%20inflammatory%20response.%22%2C%22date%22%3A%22March%201%2C%202015%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ajpath.2014.11.019%22%2C%22ISSN%22%3A%220002-9440%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0002944014006890%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-14T14%3A01%3A48Z%22%7D%7D%2C%7B%22key%22%3A%223TI2E6HV%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Nawaz%20et%20al.%22%2C%22parsedDate%22%3A%222015-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ENawaz%2C%20H.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20Elevated%20Serum%20Triglycerides%20are%20Independently%20Associated%20With%20Persistent%20Organ%20Failure%20in%20Acute%20Pancreatitis.%20%3Ci%3EAmerican%20Journal%20of%20Gastroenterology%3C%5C%2Fi%3E%20%3Cb%3E110%3C%5C%2Fb%3E%2C%201497%20%282015%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Elevated%20Serum%20Triglycerides%20are%20Independently%20Associated%20With%20Persistent%20Organ%20Failure%20in%20Acute%20Pancreatitis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Haq%22%2C%22lastName%22%3A%22Nawaz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Efstratios%22%2C%22lastName%22%3A%22Koutroumpakis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%22%2C%22lastName%22%3A%22Easler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%22%2C%22lastName%22%3A%22Slivka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20C.%22%2C%22lastName%22%3A%22Whitcomb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijay%20P.%22%2C%22lastName%22%3A%22Singh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dhiraj%22%2C%22lastName%22%3A%22Yadav%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Georgios%20I.%22%2C%22lastName%22%3A%22Papachristou%22%7D%5D%2C%22abstractNote%22%3A%22Objectives%3A%5Cu00a0Hypertriglyceridemia%20%28HTG%29%20represents%20a%20major%20health%20problem%20with%20prevalence%20exceeding%2030%25%20in%20the%20U.S.%20The%20present%20study%20aims%20to%20assess%20the%20effect%20of%20elevated%20serum%20triglyceride%20%28TG%29%20levels%20on%20the%20severity%20of%20acute%20pancreatitis%20%28AP%29.%5Cn%20%20%20%20%20%20%20%20Methods%3A%5Cu00a0Prospectively%20enrolled%20AP%20patients%20were%20categorized%20into%20normal%2C%20mild%2C%20moderate%2C%20and%20severe%5C%2Fvery%20severe%20categories%20based%20on%20their%20TG%20levels%20and%20compared%20in%20respect%20to%20demographics%2C%20comorbidities%2C%20and%20clinical%20outcomes.%20Multivariate%20analysis%20determined%20whether%20elevated%20TG%20levels%20were%20independently%20associated%20with%20persistent%20organ%20failure.%5Cn%20%20%20%20%20%20%20%20Results%3A%5Cu00a0Two%20hundred%20and%20one%20out%20of%20400%20AP%20patients%20had%20serum%20TGs%20measured%20within%2072%5Cu2009h%20of%20presentation%2C%20of%20which%20115%20had%20normal%20TG%20levels%20and%2086%20HTG%20%2820%20mild%2C%2041%20moderate%2C%20and%2025%20severe%5C%2Fvery%20severe%29.%20Patients%20with%20HTG%20were%20of%20younger%20age%20%2844%20vs.%2052%20years%29%2C%20predominantly%20male%20%2865%25%20vs.%2045%25%29%2C%20obese%20%2857%25%20vs.%2034%25%29%2C%20diabetic%20%2838%25%20vs.%2017%25%29%2C%20and%20developed%20more%20frequently%20persistent%20organ%20failure%20%2840%25%20vs.%2017%25%29%20compared%20with%20those%20with%20normal%20TGs%20%28P%3C0.02%29.%20The%20rate%20of%20persistent%20organ%20failure%20increased%20proportionally%20with%20HTG%20severity%20grades%20%2817%25%20when%20normal%20TGs%2C%2030%25%20in%20mild%2C%2039%25%20in%20moderate%2C%20and%2048%25%20in%20severe%5C%2Fvery%20severe%20HTG%2CPtrend%3C0.001%29.%20On%20multivariate%20analysis%20controlling%20for%20age%2C%20gender%2C%20body%20mass%20index%2C%20diabetes%2C%20and%20alcohol%20etiology%2C%20moderate%20HTG%20%28odds%20ratio%20%28OR%29%2C%202.6%3BP%3D0.04%29%20and%20severe%5C%2Fvery%20severe%20HTG%20%28OR%2C%204.9%3BP%3D0.009%29%20were%20independently%20associated%20with%20persistent%20organ%20failure.%5Cn%20%20%20%20%20%20%20%20Conclusions%3A%5Cu00a0Elevated%20serum%20TGs%20in%20AP%20patients%20are%20independently%20and%20proportionally%20correlated%20with%20persistent%20organ%20failure%20regardless%20of%20etiology.%20TG-mediated%20lipotoxicity%20may%20be%20an%20attractive%20target%20to%20design%20novel%20interventions%20for%20severe%20AP.%22%2C%22date%22%3A%22October%202015%22%2C%22language%22%3A%22en-US%22%2C%22DOI%22%3A%2210.1038%5C%2Fajg.2015.261%22%2C%22ISSN%22%3A%220002-9270%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fjournals.lww.com%5C%2Fajg%5C%2Ffulltext%5C%2F2015%5C%2F10000%5C%2FElevated_Serum_Triglycerides_are_Independently.24.aspx%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-14T14%3A01%3A21Z%22%7D%7D%2C%7B%22key%22%3A%22DXPVTP28%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Matthay%20and%20Zemans%22%2C%22parsedDate%22%3A%222011-01-24%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMatthay%2C%20M.%20A.%20%26amp%3B%20Zemans%2C%20R.%20L.%20The%20Acute%20Respiratory%20Distress%20Syndrome%3A%20Pathogenesis%20and%20Treatment.%20%3Ci%3EAnnu.%20Rev.%20Pathol.%20Mech.%20Dis.%3C%5C%2Fi%3E%20%3Cb%3E6%3C%5C%2Fb%3E%2C%20147%26%23x2013%3B163%20%282011%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20Acute%20Respiratory%20Distress%20Syndrome%3A%20Pathogenesis%20and%20Treatment%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20A.%22%2C%22lastName%22%3A%22Matthay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%20L.%22%2C%22lastName%22%3A%22Zemans%22%7D%5D%2C%22abstractNote%22%3A%22The%20acute%20respiratory%20distress%20syndrome%20%28ARDS%29%20causes%2040%25%20mortality%20in%20approximately%20200%2C000%20critically%20ill%20patients%20annually%20in%20the%20United%20States.%20ARDS%20is%20caused%20by%20protein-rich%20pulmonary%20edema%20that%20causes%20severe%20hypoxemia%20and%20impaired%20carbon%20dioxide%20excretion.%20The%20clinical%20disorders%20associated%20with%20the%20development%20of%20ARDS%20include%20sepsis%2C%20pneumonia%2C%20aspiration%20of%20gastric%20contents%2C%20and%20major%20trauma.%20The%20lung%20injury%20is%20caused%20primarily%20by%20neutrophil-dependent%20and%20platelet-dependent%20damage%20to%20the%20endothelial%20and%20epithelial%20barriers%20of%20the%20lung.%20Resolution%20is%20delayed%20because%20of%20injury%20to%20the%20lung%20epithelial%20barrier%2C%20which%20prevents%20removal%20of%20alveolar%20edema%20fluid%20and%20deprives%20the%20lung%20of%20adequate%20quantities%20of%20surfactant.%20Lymphocytes%20may%20play%20a%20role%20in%20resolution%20of%20lung%20injury.%20Mortality%20has%20been%20markedly%20reduced%20with%20a%20lung-protective%20ventilatory%20strategy.%20However%2C%20there%20is%20no%20effective%20pharmacologic%20therapy%2C%20although%20cell-based%20therapy%20and%20other%20therapies%20currently%20being%20tested%20in%20clinical%20trials%20may%20provide%20novel%20treatments%20for%20ARDS.%22%2C%22date%22%3A%22January%2024%2C%202011%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1146%5C%2Fannurev-pathol-011110-130158%22%2C%22ISSN%22%3A%221553-4006%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.annualreviews.org%5C%2Fdoi%5C%2F10.1146%5C%2Fannurev-pathol-011110-130158%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-14T14%3A00%3A56Z%22%7D%7D%2C%7B%22key%22%3A%22WSKT7EHE%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Habtezion%20et%20al.%22%2C%22parsedDate%22%3A%222019-05-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EHabtezion%2C%20A.%2C%20Gukovskaya%2C%20A.%20S.%20%26amp%3B%20Pandol%2C%20S.%20J.%20Acute%20Pancreatitis%3A%20A%20Multifaceted%20Set%20of%20Organelle%20and%20Cellular%26%23xA0%3BInteractions.%20%3Ci%3EGastroenterology%3C%5C%2Fi%3E%20%3Cb%3E156%3C%5C%2Fb%3E%2C%201941%26%23x2013%3B1950%20%282019%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Acute%20Pancreatitis%3A%20A%20Multifaceted%20Set%20of%20Organelle%20and%20Cellular%5Cu00a0Interactions%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aida%22%2C%22lastName%22%3A%22Habtezion%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20S.%22%2C%22lastName%22%3A%22Gukovskaya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20J.%22%2C%22lastName%22%3A%22Pandol%22%7D%5D%2C%22abstractNote%22%3A%22Acute%20pancreatitis%20is%20an%20inflammatory%20disorder%20of%20the%20exocrine%20pancreas%20associated%20with%20tissue%20injury%20and%20necrosis.%20The%20disease%20can%20be%20mild%2C%20involving%20only%20the%20pancreas%2C%20and%20resolve%20spontaneously%20within%20days%20or%20severe%2C%20with%20systemic%20inflammatory%20response%20syndrome%5Cu2013associated%20extrapancreatic%20organ%20failure%20and%20even%20death.%20Importantly%2C%20there%20are%20no%20therapeutic%20agents%20currently%20in%20use%20that%20can%20alter%20the%20course%20of%20the%20disease.%20This%20article%20emphasizes%20emerging%20findings%20that%20stressors%20%28environmental%20and%20genetic%29%20that%20cause%20acute%20pancreatitis%20initially%20cause%20injury%20to%20organelles%20of%20the%20acinar%20cell%20%28endoplasmic%20reticulum%2C%20mitochondria%2C%20and%20endolysosomal%5Cu2013autophagy%20system%29%2C%20and%20that%20disorders%20in%20the%20functions%20of%20the%20organelles%20lead%20to%20inappropriate%20intracellular%20activation%20of%20trypsinogen%20and%20inflammatory%20pathways.%20We%20also%20review%20emerging%20work%20on%20the%20role%20of%20damage-associated%20molecular%20patterns%20in%20mediating%20the%20local%20and%20systemic%20inflammatory%20response%20in%20addition%20to%20known%20cytokines%20and%20chemokine%20pathways.%20In%20the%20review%2C%20we%20provide%20considerations%20for%20correction%20of%20organelle%20functions%20in%20acute%20pancreatitis%20to%20create%20a%20discussion%20for%20clinical%20trial%20treatment%20and%20design%20options.%22%2C%22date%22%3A%22May%201%2C%202019%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1053%5C%2Fj.gastro.2018.11.082%22%2C%22ISSN%22%3A%220016-5085%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0016508519300551%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-14T14%3A00%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22WEPKSYBK%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Durgampudi%20et%20al.%22%2C%22parsedDate%22%3A%222014-06-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDurgampudi%2C%20C.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20Acute%20Lipotoxicity%20Regulates%20Severity%20of%20Biliary%20Acute%20Pancreatitis%20without%20Affecting%20Its%20Initiation.%20%3Ci%3EThe%20American%20Journal%20of%20Pathology%3C%5C%2Fi%3E%20%3Cb%3E184%3C%5C%2Fb%3E%2C%201773%26%23x2013%3B1784%20%282014%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Acute%20Lipotoxicity%20Regulates%20Severity%20of%20Biliary%20Acute%20Pancreatitis%20without%20Affecting%20Its%20Initiation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chandra%22%2C%22lastName%22%3A%22Durgampudi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pawan%22%2C%22lastName%22%3A%22Noel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Krutika%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%22%2C%22lastName%22%3A%22Cline%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ram%20N.%22%2C%22lastName%22%3A%22Trivedi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20P.%22%2C%22lastName%22%3A%22DeLany%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dhiraj%22%2C%22lastName%22%3A%22Yadav%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Georgios%20I.%22%2C%22lastName%22%3A%22Papachristou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenneth%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chathur%22%2C%22lastName%22%3A%22Acharya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deepthi%22%2C%22lastName%22%3A%22Jaligama%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Navina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faris%22%2C%22lastName%22%3A%22Murad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijay%20P.%22%2C%22lastName%22%3A%22Singh%22%7D%5D%2C%22abstractNote%22%3A%22Obese%20patients%20have%20worse%20outcomes%20during%20acute%20pancreatitis%20%28AP%29.%20Previous%20animal%20models%20of%20AP%20have%20found%20worse%20outcomes%20in%20obese%20rodents%20who%20may%20have%20a%20baseline%20proinflammatory%20state.%20Our%20aim%20was%20to%20study%20the%20role%20of%20acute%20lipolytic%20generation%20of%20fatty%20acids%20on%20local%20severity%20and%20systemic%20complications%20of%20AP.%20Human%20postpancreatitis%20necrotic%20collections%20were%20analyzed%20for%20unsaturated%20fatty%20acids%20%28UFAs%29%20and%20saturated%20fatty%20acids.%20A%20model%20of%20biliary%20AP%20was%20designed%20to%20replicate%20the%20human%20variables%20by%20intraductal%20injection%20of%20the%20triglyceride%20glyceryl%20trilinoleate%20alone%20or%20with%20the%20chemically%20distinct%20lipase%20inhibitors%20orlistat%20or%20cetilistat.%20Parameters%20of%20AP%20etiology%20and%20outcomes%20of%20local%20and%20systemic%20severity%20were%20measured.%20Patients%20with%20postpancreatitis%20necrotic%20collections%20were%20obese%2C%20and%2013%20of%2015%20had%20biliary%20AP.%20Postpancreatitis%20necrotic%20collections%20were%20enriched%20in%20UFAs.%20Intraductal%20glyceryl%20trilinoleate%20with%20or%20without%20the%20lipase%20inhibitors%20resulted%20in%20oil%20red%20O%5Cu2013positive%20areas%2C%20resembling%20intrapancreatic%20fat.%20Both%20lipase%20inhibitors%20reduced%20the%20glyceryl%20trilinoleate%5Cu2013induced%20increase%20in%20serum%20lipase%2C%20UFAs%2C%20pancreatic%20necrosis%2C%20serum%20inflammatory%20markers%2C%20systemic%20injury%2C%20and%20mortality%20but%20not%20serum%20alanine%20aminotransferase%2C%20bilirubin%2C%20or%20amylase.%20We%20conclude%20that%20UFAs%20are%20enriched%20in%20human%20necrotic%20collections%20and%20acute%20UFA%20generation%20via%20lipolysis%20worsens%20pancreatic%20necrosis%2C%20systemic%20inflammation%2C%20and%20injury%20associated%20with%20severe%20AP.%20Inhibition%20of%20lipolysis%20reduces%20UFA%20generation%20and%20improves%20these%20outcomes%20of%20AP%20without%20interfering%20with%20its%20induction.%22%2C%22date%22%3A%22June%201%2C%202014%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ajpath.2014.02.015%22%2C%22ISSN%22%3A%220002-9440%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0002944014001680%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-14T13%3A59%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22QEJ8WGZI%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Garg%20and%20Singh%22%2C%22parsedDate%22%3A%222019-05-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGarg%2C%20P.%20K.%20%26amp%3B%20Singh%2C%20V.%20P.%20Organ%20Failure%20Due%20to%20Systemic%20Injury%20in%20Acute%20Pancreatitis.%20%3Ci%3EGastroenterology%3C%5C%2Fi%3E%20%3Cb%3E156%3C%5C%2Fb%3E%2C%202008%26%23x2013%3B2023%20%282019%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Organ%20Failure%20Due%20to%20Systemic%20Injury%20in%20Acute%20Pancreatitis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Parmod%20K.%22%2C%22lastName%22%3A%22Garg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijay%20P.%22%2C%22lastName%22%3A%22Singh%22%7D%5D%2C%22abstractNote%22%3A%22Acute%20pancreatitis%20may%20be%20associated%20with%20both%20local%20and%20systemic%20complications.%20Systemic%20injury%20manifests%20in%20the%20form%20of%20organ%20failure%2C%20which%20is%20seen%20in%20approximately%2020%25%20of%20all%20cases%20of%20acute%20pancreatitis%20and%20defines%20%5Cu201csevere%20acute%20pancreatitis.%5Cu201d%20Organ%20failure%20typically%20develops%20early%20in%20the%20course%20of%20acute%20pancreatitis%2C%20but%20also%20may%20develop%20later%20due%20to%20infected%20pancreatic%20necrosis%5Cu2013induced%20sepsis.%20Organ%20failure%20is%20the%20most%20important%20determinant%20of%20outcome%20in%20acute%20pancreatitis.%20We%20review%20here%20the%20current%20understanding%20of%20the%20risk%20factors%2C%20pathophysiology%2C%20timing%2C%20impact%20on%20outcome%2C%20and%20therapy%20of%20organ%20failure%20in%20acute%20pancreatitis.%20As%20we%20discuss%20the%20pathophysiology%20of%20severe%20systemic%20injury%2C%20the%20distinctions%20between%20markers%20and%20mediators%20of%20severity%20are%20highlighted%20based%20on%20evidence%20supporting%20their%20causality%20in%20organ%20failure.%20Emphasis%20is%20placed%20on%20clinically%20relevant%20end%20points%20of%20organ%20failure%20and%20the%20mechanisms%20underlying%20the%20pathophysiological%20perturbations%2C%20which%20offer%20insight%20into%20potential%20therapeutic%20targets%20to%20treat.%22%2C%22date%22%3A%22May%201%2C%202019%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1053%5C%2Fj.gastro.2018.12.041%22%2C%22ISSN%22%3A%220016-5085%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0016508519301027%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-14T13%3A58%3A19Z%22%7D%7D%2C%7B%22key%22%3A%22QPDAAVIW%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Xiao%20et%20al.%22%2C%22parsedDate%22%3A%222016%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EXiao%2C%20A.%20Y.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20Global%20incidence%20and%20mortality%20of%20pancreatic%20diseases%3A%20a%20systematic%20review%2C%20meta-analysis%2C%20and%20meta-regression%20of%20population-based%20cohort%20studies.%20%3Ci%3ELancet%20Gastroenterol%20Hepatol%3C%5C%2Fi%3E%20%3Cb%3E1%3C%5C%2Fb%3E%2C%2045%26%23x2013%3B55%20%282016%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Global%20incidence%20and%20mortality%20of%20pancreatic%20diseases%3A%20a%20systematic%20review%2C%20meta-analysis%2C%20and%20meta-regression%20of%20population-based%20cohort%20studies%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%20Y.%22%2C%22lastName%22%3A%22Xiao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marianne%20L.%20Y.%22%2C%22lastName%22%3A%22Tan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Landy%20M.%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Varsha%20M.%22%2C%22lastName%22%3A%22Asrani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20A.%22%2C%22lastName%22%3A%22Windsor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dhiraj%22%2C%22lastName%22%3A%22Yadav%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maxim%20S.%22%2C%22lastName%22%3A%22Petrov%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20There%20is%20a%20lack%20of%20robust%20estimates%20of%20the%20worldwide%20incidence%20and%20mortality%20of%20acute%20pancreatitis%2C%20chronic%20pancreatitis%2C%20pancreatic%20cysts%2C%20and%20pancreatic%20cancer%20in%20the%20general%20population.%20Our%20aim%20was%20to%20quantitate%20and%20compare%20the%20incidence%20and%20mortality%20of%20major%20pancreatic%20diseases%20in%20high-quality%20population-based%20cohort%20studies.%5CnMETHODS%3A%20Three%20databases%20%28PubMed%2C%20Embase%2C%20and%20Scopus%29%20were%20searched%20independently%20by%20two%20reviewers.%20Data%20from%20eligible%20studies%20were%20subject%20to%20meta-analysis%20to%20obtain%20global%20estimates.%20A%20number%20of%20prespecified%20subgroup%20analyses%20and%20meta-regression%20analyses%20were%20also%20done.%5CnFINDINGS%3A%2048%20population-based%20cohort%20studies%20%2835%20on%20pancreatic%20cancer%2C%20ten%20on%20acute%20pancreatitis%2C%20three%20on%20chronic%20pancreatitis%2C%20and%20none%20on%20pancreatic%20cysts%29%20were%20identified%2C%20with%20a%20total%20study%20population%20of%20296%20million%20individuals%20and%20119%5Cu2008000%20patients%20with%20pancreatic%20diseases.%20Global%20estimates%20of%20incidence%20and%20mortality%20were%208%5Cu00b714%20cases%20%2895%25%20CI%206%5Cu00b763-9%5Cu00b798%29%20per%20100%5Cu2008000%20person-years%20and%206%5Cu00b792%20deaths%20%2895%25%20CI%203%5Cu00b772-12%5Cu00b789%29%20per%20100%5Cu2008000%20person-years%20for%20pancreatic%20cancer%2C%2033%5Cu00b774%20cases%20%2895%25%20CI%2023%5Cu00b733-48%5Cu00b781%29%20per%20100%5Cu2008000%20person-years%20and%201%5Cu00b760%20deaths%20%2895%25%20CI%200%5Cu00b785-1%5Cu00b758%29%20per%20100%5Cu2008000%20person-years%20for%20acute%20pancreatitis%2C%20and%209%5Cu00b762%20cases%20%2895%25%20CI%207%5Cu00b786-11%5Cu00b778%29%20per%20100%5Cu2008000%20person-years%20and%200%5Cu00b709%20deaths%20%2895%25%20CI%200%5Cu00b702-0%5Cu00b747%29%20per%20100%5Cu2008000%20person-years%20for%20chronic%20pancreatitis.%20Subgroup%20analysis%20based%20on%20the%20WHO%20regions%20showed%20that%20the%20incidences%20of%20both%20pancreatic%20cancer%20and%20acute%20pancreatitis%2C%20and%20mortality%20from%20pancreatic%20cancer%2C%20were%20significantly%20higher%20in%20the%20American%20region%20than%20in%20the%20European%20and%20Western%20Pacific%20regions%2C%20while%20the%20incidence%20of%20chronic%20pancreatitis%20was%20significantly%20higher%20in%20the%20European%20region%20than%20in%20the%20American%20region.%20Mortality%20from%20pancreatic%20cancer%20was%20lowest%20in%20the%20Southeast%20Asian%20region.%20The%20incidence%20of%20chronic%20pancreatitis%20was%20twice%20as%20high%20in%20men%20as%20in%20women%2C%20although%20there%20was%20no%20difference%20between%20sexes%20for%20pancreatic%20cancer%20or%20acute%20pancreatitis.%5CnINTERPRETATION%3A%20Globally%2C%20acute%20pancreatitis%20is%20the%20most%20common%20pancreatic%20disease%20whilst%20pancreatic%20cancer%20is%20the%20most%20lethal.%20However%2C%20their%20burden%20is%20not%20equal%20across%20the%20globe.%20The%20epidemiological%20estimates%20reported%20in%20this%20study%20could%20inform%20future%20high-quality%20studies.%5CnFUNDING%3A%20None.%22%2C%22date%22%3A%2209%202016%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2FS2468-1253%2816%2930004-8%22%2C%22ISSN%22%3A%222468-1253%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-14T13%3A35%3A56Z%22%7D%7D%2C%7B%22key%22%3A%22DMBYNGS3%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Yadav%20and%20Lowenfels%22%2C%22parsedDate%22%3A%222013-06%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EYadav%2C%20D.%20%26amp%3B%20Lowenfels%2C%20A.%20B.%20The%20epidemiology%20of%20pancreatitis%20and%20pancreatic%20cancer.%20%3Ci%3EGastroenterology%3C%5C%2Fi%3E%20%3Cb%3E144%3C%5C%2Fb%3E%2C%201252%26%23x2013%3B1261%20%282013%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20epidemiology%20of%20pancreatitis%20and%20pancreatic%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dhiraj%22%2C%22lastName%22%3A%22Yadav%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%20B.%22%2C%22lastName%22%3A%22Lowenfels%22%7D%5D%2C%22abstractNote%22%3A%22Acute%20pancreatitis%20is%20one%20of%20the%20most%20frequent%20gastrointestinal%20causes%20of%20hospital%20admission%20in%20the%20United%20States.%20Chronic%20pancreatitis%2C%20although%20lower%20in%20incidence%2C%20significantly%20reduces%20patients%27%20quality%20of%20life.%20Pancreatic%20cancer%20is%20associated%20with%20a%20high%20mortality%20rate%20and%20is%20one%20of%20the%20top%205%20causes%20of%20death%20from%20cancer.%20The%20burden%20of%20pancreatic%20disorders%20is%20expected%20to%20increase%20over%20time.%20The%20risk%20and%20etiology%20of%20pancreatitis%20differ%20with%20age%20and%20sex%2C%20and%20all%20pancreatic%20disorders%20affect%20the%20black%20population%20more%20than%20any%20other%20race.%20Gallstones%20are%20the%20most%20common%20cause%20of%20acute%20pancreatitis%2C%20and%20early%20cholecystectomy%20eliminates%20the%20risk%20of%20future%20attacks.%20Alcohol%20continues%20to%20be%20the%20single%20most%20important%20risk%20factor%20for%20chronic%20pancreatitis.%20Smoking%20is%20an%20independent%20risk%20factor%20for%20acute%20and%20chronic%20pancreatitis%2C%20and%20its%20effects%20could%20synergize%20with%20those%20of%20alcohol.%20Significant%20risk%20factors%20for%20pancreatic%20cancer%20include%20smoking%20and%20non-O%20blood%20groups.%20Alcohol%20abstinence%20and%20smoking%20cessation%20can%20alter%20the%20progression%20of%20pancreatitis%20and%20reduce%20recurrence%3B%20smoking%20cessation%20is%20the%20most%20effective%20strategy%20to%20reduce%20the%20risk%20of%20pancreatic%20cancer.%22%2C%22date%22%3A%22Jun%202013%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1053%5C%2Fj.gastro.2013.01.068%22%2C%22ISSN%22%3A%221528-0012%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-14T13%3A29%3A44Z%22%7D%7D%2C%7B%22key%22%3A%223L6UD3CX%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Peery%20et%20al.%22%2C%22parsedDate%22%3A%222012-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPeery%2C%20A.%20F.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20Burden%20of%20gastrointestinal%20disease%20in%20the%20United%20States%3A%202012%20update.%20%3Ci%3EGastroenterology%3C%5C%2Fi%3E%20%3Cb%3E143%3C%5C%2Fb%3E%2C%201179-1187.e3%20%282012%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Burden%20of%20gastrointestinal%20disease%20in%20the%20United%20States%3A%202012%20update%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%20F.%22%2C%22lastName%22%3A%22Peery%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Evan%20S.%22%2C%22lastName%22%3A%22Dellon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Lund%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Seth%20D.%22%2C%22lastName%22%3A%22Crockett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20E.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20J.%22%2C%22lastName%22%3A%22Bulsiewicz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lisa%20M.%22%2C%22lastName%22%3A%22Gangarosa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michelle%20T.%22%2C%22lastName%22%3A%22Thiny%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karyn%22%2C%22lastName%22%3A%22Stizenberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Douglas%20R.%22%2C%22lastName%22%3A%22Morgan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yehuda%22%2C%22lastName%22%3A%22Ringel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hannah%20P.%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marco%20Dacosta%22%2C%22lastName%22%3A%22DiBonaventura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charlotte%20F.%22%2C%22lastName%22%3A%22Carroll%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffery%20K.%22%2C%22lastName%22%3A%22Allen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suzanne%20F.%22%2C%22lastName%22%3A%22Cook%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20S.%22%2C%22lastName%22%3A%22Sandler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20D.%22%2C%22lastName%22%3A%22Kappelman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%20J.%22%2C%22lastName%22%3A%22Shaheen%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%20%26%20AIMS%3A%20Gastrointestinal%20%28GI%29%20diseases%20account%20for%20substantial%20morbidity%2C%20mortality%2C%20and%20cost.%20Statistical%20analyses%20of%20the%20most%20recent%20data%20are%20necessary%20to%20guide%20GI%20research%2C%20education%2C%20and%20clinical%20practice.%20We%20estimate%20the%20burden%20of%20GI%20disease%20in%20the%20United%20States.%5CnMETHODS%3A%20We%20collected%20information%20on%20the%20epidemiology%20of%20GI%20diseases%20%28including%20cancers%29%20and%20symptoms%2C%20along%20with%20data%20on%20resource%20utilization%2C%20quality%20of%20life%2C%20impairments%20to%20work%20and%20activity%2C%20morbidity%2C%20and%20mortality.%20These%20data%20were%20obtained%20from%20the%20National%20Ambulatory%20Medical%20Care%20Survey%3B%20National%20Health%20and%20Wellness%20Survey%3B%20Nationwide%20Inpatient%20Sample%3B%20Surveillance%2C%20Epidemiology%2C%20and%20End%20Results%20Program%3B%20National%20Vital%20Statistics%20System%3B%20Thompson%20Reuters%20MarketScan%3B%20Medicare%3B%20Medicaid%3B%20and%20the%20Clinical%20Outcomes%20Research%20Initiative%27s%20National%20Endoscopic%20Database.%20We%20estimated%20endoscopic%20use%20and%20costs%20and%20examined%20trends%20in%20endoscopic%20procedure.%5CnRESULTS%3A%20Abdominal%20pain%20was%20the%20most%20common%20GI%20symptom%20that%20prompted%20a%20clinic%20visit%20%2815.9%20million%20visits%29.%20Gastroesophageal%20reflux%20was%20the%20most%20common%20GI%20diagnosis%20%288.9%20million%20visits%29.%20Hospitalizations%20and%20mortality%20from%20Clostridium%20difficile%20infection%20have%20doubled%20in%20the%20last%2010%20years.%20Acute%20pancreatitis%20was%20the%20most%20common%20reason%20for%20hospitalization%20%28274%2C119%20discharges%29.%20Colorectal%20cancer%20accounted%20for%20more%20than%20half%20of%20all%20GI%20cancers%20and%20was%20the%20leading%20cause%20of%20GI-related%20mortality%20%2852%2C394%20deaths%29.%20There%20were%206.9%20million%20upper%2C%2011.5%20million%20lower%2C%20and%20228%2C000%20biliary%20endoscopies%20performed%20in%202009.%20The%20total%20cost%20for%20outpatient%20GI%20endoscopy%20examinations%20was%20%2432.4%20billion.%5CnCONCLUSIONS%3A%20GI%20diseases%20are%20a%20source%20of%20substantial%20morbidity%2C%20mortality%2C%20and%20cost%20in%20the%20United%20States.%22%2C%22date%22%3A%22Nov%202012%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1053%5C%2Fj.gastro.2012.08.002%22%2C%22ISSN%22%3A%221528-0012%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-14T13%3A29%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22IT3F6GHD%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lasher%20et%20al.%22%2C%22parsedDate%22%3A%222019-06%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELasher%2C%20D.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20Protease-Sensitive%20Pancreatic%20Lipase%20Variants%20Are%20Associated%20With%20Early%20Onset%20Chronic%20Pancreatitis.%20%3Ci%3EAm.%20J.%20Gastroenterol.%3C%5C%2Fi%3E%20%3Cb%3E114%3C%5C%2Fb%3E%2C%20974%26%23x2013%3B983%20%282019%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Protease-Sensitive%20Pancreatic%20Lipase%20Variants%20Are%20Associated%20With%20Early%20Onset%20Chronic%20Pancreatitis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denise%22%2C%22lastName%22%3A%22Lasher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andr%5Cu00e1s%22%2C%22lastName%22%3A%22Szab%5Cu00f3%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Atsushi%22%2C%22lastName%22%3A%22Masamune%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jian-Min%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xunjun%22%2C%22lastName%22%3A%22Xiao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20C.%22%2C%22lastName%22%3A%22Whitcomb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20Michael%22%2C%22lastName%22%3A%22Barmada%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maren%22%2C%22lastName%22%3A%22Ewers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%22%2C%22lastName%22%3A%22Ruffert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sumit%22%2C%22lastName%22%3A%22Paliwal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Prachand%22%2C%22lastName%22%3A%22Issarapu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Seema%22%2C%22lastName%22%3A%22Bhaskar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20Radha%22%2C%22lastName%22%3A%22Mani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giriraj%20R.%22%2C%22lastName%22%3A%22Chandak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helmut%22%2C%22lastName%22%3A%22Laumen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Masson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kiyoshi%22%2C%22lastName%22%3A%22Kume%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shin%22%2C%22lastName%22%3A%22Hamada%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eriko%22%2C%22lastName%22%3A%22Nakano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katharina%22%2C%22lastName%22%3A%22Seltsam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Bugert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22M%5Cu00fcller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20A.%22%2C%22lastName%22%3A%22Groneberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tooru%22%2C%22lastName%22%3A%22Shimosegawa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonas%22%2C%22lastName%22%3A%22Rosendahl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claude%22%2C%22lastName%22%3A%22F%5Cu00e9rec%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20E.%22%2C%22lastName%22%3A%22Lowe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heiko%22%2C%22lastName%22%3A%22Witt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mikl%5Cu00f3s%22%2C%22lastName%22%3A%22Sahin-T%5Cu00f3th%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20Premature%20activation%20of%20the%20digestive%20protease%20trypsin%20within%20the%20pancreatic%20parenchyma%20is%20a%20critical%20factor%20in%20the%20pathogenesis%20of%20pancreatitis.%20Alterations%20in%20genes%20that%20affect%20intrapancreatic%20trypsin%20activity%20are%20associated%20with%20chronic%20pancreatitis%20%28CP%29.%20Recently%2C%20carboxyl%20ester%20lipase%20emerged%20as%20a%20trypsin-independent%20risk%20gene.%20Here%2C%20we%20evaluated%20pancreatic%20lipase%20%28PNLIP%29%20as%20a%20potential%20novel%20susceptibility%20gene%20for%20CP.%5CnMETHODS%3A%20We%20analyzed%20all%2013%20PNLIP%20exons%20in%20429%20nonalcoholic%20patients%20with%20CP%20and%20600%20control%20subjects%20from%20Germany%2C%20in%20632%20patients%20and%20957%20controls%20from%20France%2C%20and%20in%20223%20patients%20and%201%2C070%20controls%20from%20Japan%20by%20DNA%20sequencing.%20Additionally%2C%20we%20analyzed%20selected%20exons%20in%20further%20545%20patients%20with%20CP%20and%201%2C849%20controls%20originating%20from%20Germany%2C%20United%20States%2C%20and%20India.%20We%20assessed%20the%20cellular%20secretion%2C%20lipase%20activity%2C%20and%20proteolytic%20stability%20of%20recombinant%20PNLIP%20variants.%5CnRESULTS%3A%20In%20the%20German%20discovery%20cohort%2C%208%5C%2F429%20%281.9%25%29%20patients%20and%202%5C%2F600%20%280.3%25%29%20controls%20carried%20a%20PNLIP%20missense%20variant%20%28P%20%3D%200.02%2C%20odds%20ratio%20%5BOR%5D%20%3D%205.7%2C%2095%25%20confidence%20interval%20%5BCI%5D%20%3D%201.1-38.9%29.%20Variants%20detected%20in%20patients%20were%20prone%20to%20proteolytic%20degradation%20by%20trypsin%20and%20chymotrypsin.%20In%20the%20French%20replication%20cohort%2C%20protease-sensitive%20variants%20were%20also%20enriched%20in%20patients%20with%20early-onset%20CP%20%285%5C%2F632%20%5B0.8%25%5D%29%20vs%20controls%20%281%5C%2F957%20%5B0.1%25%5D%29%20%28P%20%3D%200.04%2C%20OR%20%3D%207.6%2C%2095%25%20CI%20%3D%200.9-172.9%29.%20In%20contrast%2C%20we%20detected%20no%20protease-sensitive%20variants%20in%20the%20non-European%20populations.%20In%20the%20combined%20European%20data%2C%20protease-sensitive%20variants%20were%20found%20in%2013%5C%2F1%2C163%20cases%20%281.1%25%29%20and%20in%203%5C%2F3%2C000%20controls%20%280.1%25%29%20%28OR%20%3D%2011.3%2C%2095%25%20CI%20%3D%203.0-49.9%2C%20P%20%3C%200.0001%29.%5CnCONCLUSIONS%3A%20Our%20data%20indicate%20that%20protease-sensitive%20PNLIP%20variants%20are%20novel%20genetic%20risk%20factors%20for%20the%20development%20of%20CP.%22%2C%22date%22%3A%22Jun%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.14309%5C%2Fajg.0000000000000051%22%2C%22ISSN%22%3A%221572-0241%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-14T00%3A07%3A14Z%22%7D%7D%2C%7B%22key%22%3A%22CJDD5JK3%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Navina%20et%20al.%22%2C%22parsedDate%22%3A%222011-11-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ENavina%2C%20S.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20Lipotoxicity%20causes%20multisystem%20organ%20failure%20and%20exacerbates%20acute%20pancreatitis%20in%20obesity.%20%3Ci%3ESci%20Transl%20Med%3C%5C%2Fi%3E%20%3Cb%3E3%3C%5C%2Fb%3E%2C%20107ra110%20%282011%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Lipotoxicity%20causes%20multisystem%20organ%20failure%20and%20exacerbates%20acute%20pancreatitis%20in%20obesity%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Navina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chathur%22%2C%22lastName%22%3A%22Acharya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20P.%22%2C%22lastName%22%3A%22DeLany%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lidiya%20S.%22%2C%22lastName%22%3A%22Orlichenko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20J.%22%2C%22lastName%22%3A%22Baty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sruti%20S.%22%2C%22lastName%22%3A%22Shiva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chandra%22%2C%22lastName%22%3A%22Durgampudi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jenny%20M.%22%2C%22lastName%22%3A%22Karlsson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenneth%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kyongtae%20T.%22%2C%22lastName%22%3A%22Bae%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alessandro%22%2C%22lastName%22%3A%22Furlan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jaideep%22%2C%22lastName%22%3A%22Behari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shiguang%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Teresa%22%2C%22lastName%22%3A%22McHale%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Larry%22%2C%22lastName%22%3A%22Nichols%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Georgios%20Ioannis%22%2C%22lastName%22%3A%22Papachristou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dhiraj%22%2C%22lastName%22%3A%22Yadav%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijay%20P.%22%2C%22lastName%22%3A%22Singh%22%7D%5D%2C%22abstractNote%22%3A%22Obesity%20increases%20the%20risk%20of%20adverse%20outcomes%20during%20acute%20critical%20illnesses%20such%20as%20burns%2C%20severe%20trauma%2C%20and%20acute%20pancreatitis.%20Although%20individuals%20with%20more%20body%20fat%20and%20higher%20serum%20cytokines%20and%20lipase%20are%20more%20likely%20to%20experience%20problems%2C%20the%20roles%20that%20these%20characteristics%20play%20are%20not%20clear.%20We%20used%20severe%20acute%20pancreatitis%20as%20a%20representative%20disease%20to%20investigate%20the%20effects%20of%20obesity%20on%20local%20organ%20function%20and%20systemic%20processes.%20In%20obese%20humans%2C%20we%20found%20that%20an%20increase%20in%20the%20volume%20of%20intrapancreatic%20adipocytes%20was%20associated%20with%20more%20extensive%20pancreatic%20necrosis%20during%20acute%20pancreatitis%20and%20that%20acute%20pancreatitis%20was%20associated%20with%20multisystem%20organ%20failure%20in%20obese%20individuals.%20In%20vitro%20studies%20of%20pancreatic%20acinar%20cells%20showed%20that%20unsaturated%20fatty%20acids%20were%20proinflammatory%2C%20releasing%20intracellular%20calcium%2C%20inhibiting%20mitochondrial%20complexes%20I%20and%20V%2C%20and%20causing%20necrosis.%20Saturated%20fatty%20acids%20had%20no%20such%20effects.%20Inhibition%20of%20lipolysis%20in%20obese%20%28ob%5C%2Fob%29%20mice%20with%20induced%20pancreatitis%20prevented%20a%20rise%20in%20serum%20unsaturated%20fatty%20acids%20and%20prevented%20renal%20injury%2C%20lung%20injury%2C%20systemic%20inflammation%2C%20hypocalcemia%2C%20reduced%20pancreatic%20necrosis%2C%20and%20mortality.%20Thus%2C%20therapeutic%20approaches%20that%20target%20unsaturated%20fatty%20acid-mediated%20lipotoxicity%20may%20reduce%20adverse%20outcomes%20in%20obese%20patients%20with%20critical%20illnesses%20such%20as%20severe%20acute%20pancreatitis.%22%2C%22date%22%3A%22Nov%2002%2C%202011%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1126%5C%2Fscitranslmed.3002573%22%2C%22ISSN%22%3A%221946-6242%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-13T23%3A51%3A14Z%22%7D%7D%2C%7B%22key%22%3A%229FP8AHJD%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Noel%20et%20al.%22%2C%22parsedDate%22%3A%222016-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ENoel%2C%20P.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20Peripancreatic%20fat%20necrosis%20worsens%20acute%20pancreatitis%20independent%20of%20pancreatic%20necrosis%20via%20unsaturated%20fatty%20acids%20increased%20in%20human%20pancreatic%20necrosis%20collections.%20%3Ci%3EGut%3C%5C%2Fi%3E%20%3Cb%3E65%3C%5C%2Fb%3E%2C%20100%26%23x2013%3B111%20%282016%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Peripancreatic%20fat%20necrosis%20worsens%20acute%20pancreatitis%20independent%20of%20pancreatic%20necrosis%20via%20unsaturated%20fatty%20acids%20increased%20in%20human%20pancreatic%20necrosis%20collections%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pawan%22%2C%22lastName%22%3A%22Noel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Krutika%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chandra%22%2C%22lastName%22%3A%22Durgampudi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ram%20N.%22%2C%22lastName%22%3A%22Trivedi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cristiane%22%2C%22lastName%22%3A%22de%20Oliveira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20D.%22%2C%22lastName%22%3A%22Crowell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rahul%22%2C%22lastName%22%3A%22Pannala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenneth%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Randall%22%2C%22lastName%22%3A%22Brand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Chennat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%22%2C%22lastName%22%3A%22Slivka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Georgios%20I.%22%2C%22lastName%22%3A%22Papachristou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Asif%22%2C%22lastName%22%3A%22Khalid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20C.%22%2C%22lastName%22%3A%22Whitcomb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20P.%22%2C%22lastName%22%3A%22DeLany%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%20A.%22%2C%22lastName%22%3A%22Cline%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chathur%22%2C%22lastName%22%3A%22Acharya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deepthi%22%2C%22lastName%22%3A%22Jaligama%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faris%20M.%22%2C%22lastName%22%3A%22Murad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dhiraj%22%2C%22lastName%22%3A%22Yadav%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Navina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijay%20P.%22%2C%22lastName%22%3A%22Singh%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%20AND%20AIMS%3A%20Peripancreatic%20fat%20necrosis%20occurs%20frequently%20in%20necrotising%20pancreatitis.%20Distinguishing%20markers%20from%20mediators%20of%20severe%20acute%20pancreatitis%20%28SAP%29%20is%20important%20since%20targeting%20mediators%20may%20improve%20outcomes.%20We%20evaluated%20potential%20agents%20in%20human%20pancreatic%20necrotic%20collections%20%28NCs%29%2C%20pseudocysts%20%28PCs%29%20and%20pancreatic%20cystic%20neoplasms%20and%20used%20pancreatic%20acini%2C%20peripheral%20blood%20mononuclear%20cells%20%28PBMC%29%20and%20an%20acute%20pancreatitis%20%28AP%29%20model%20to%20determine%20SAP%20mediators.%5CnMETHODS%3A%20We%20measured%20acinar%20and%20PBMC%20injury%20induced%20by%20agents%20increased%20in%20NCs%20and%20PCs.%20Outcomes%20of%20caerulein%20pancreatitis%20were%20studied%20in%20lean%20rats%20coadministered%20interleukin%20%28IL%29-1%5Cu03b2%20and%20keratinocyte%20chemoattractant%5C%2Fgrowth-regulated%20oncogene%2C%20triolein%20alone%20or%20with%20the%20lipase%20inhibitor%20orlistat.%5CnRESULTS%3A%20NCs%20had%20higher%20fatty%20acids%2C%20IL-8%20and%20IL-1%5Cu03b2%20versus%20other%20fluids.%20Lipolysis%20of%20unsaturated%20triglyceride%20and%20resulting%20unsaturated%20fatty%20acids%20%28UFA%29%20oleic%20and%20linoleic%20acids%20induced%20necro-apoptosis%20at%20less%20than%20half%20the%20concentration%20in%20NCs%20but%20other%20agents%20did%20not%20do%20so%20at%20more%20than%20two%20times%20these%20concentrations.%20Cytokine%20coadministration%20resulted%20in%20higher%20pancreatic%20and%20lung%20inflammation%20than%20caerulein%20alone%2C%20but%20only%20triolein%20coadministration%20caused%20peripancreatic%20fat%20stranding%2C%20higher%20cytokines%2C%20UFAs%2C%20multisystem%20organ%20failure%20%28MSOF%29%20and%20mortality%20in%2097%25%20animals%2C%20which%20were%20prevented%20by%20orlistat.%5CnCONCLUSIONS%3A%20UFAs%2C%20IL-1%5Cu03b2%20and%20IL-8%20are%20elevated%20in%20NCs.%20However%2C%20UFAs%20generated%20via%20peripancreatic%20fat%20lipolysis%20causes%20worse%20inflammation%20and%20MSOF%2C%20converting%20mild%20AP%20to%20SAP.%22%2C%22date%22%3A%22Jan%202016%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1136%5C%2Fgutjnl-2014-308043%22%2C%22ISSN%22%3A%221468-3288%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FP6DH93X%22%5D%2C%22dateModified%22%3A%222019-08-13T23%3A50%3A26Z%22%7D%7D%2C%7B%22key%22%3A%22BGWH7SX8%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Song%20et%20al.%22%2C%22parsedDate%22%3A%222019-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESong%2C%20E.%20J.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20Investigating%20a%20chimeric%20anti-mouse%20PDGFR%26%23x3B1%3B%20antibody%20as%20a%20radiosensitizer%20in%20primary%20mouse%20sarcomas.%20%3Ci%3EEBioMedicine%3C%5C%2Fi%3E%20%3Cb%3E40%3C%5C%2Fb%3E%2C%20224%26%23x2013%3B230%20%282019%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Investigating%20a%20chimeric%20anti-mouse%20PDGFR%5Cu03b1%20antibody%20as%20a%20radiosensitizer%20in%20primary%20mouse%20sarcomas%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erin%20J.%22%2C%22lastName%22%3A%22Song%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathleen%20A.%22%2C%22lastName%22%3A%22Ashcraft%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%20D.%22%2C%22lastName%22%3A%22Lowery%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yvonne%20M.%22%2C%22lastName%22%3A%22Mowery%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lixia%22%2C%22lastName%22%3A%22Luo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yan%22%2C%22lastName%22%3A%22Ma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorraine%20Da%20Silva%22%2C%22lastName%22%3A%22Campos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Diana%20M.%22%2C%22lastName%22%3A%22Cardona%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Louis%22%2C%22lastName%22%3A%22Stancato%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20G.%22%2C%22lastName%22%3A%22Kirsch%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Olaratumab%20%28LY3012207%5C%2FIMC-3G3%5C%2FLartruvo%5Cu2122%29%20is%20a%20fully%20human%20monoclonal%20antibody%20specific%20for%20platelet-derived%20growth%20factor%20receptor%20alpha%20%28PDGFR%5Cu03b1%29.%20Phase%20Ib%5C%2FII%20trial%20results%20of%20olaratumab%20plus%20doxorubicin%20in%20adult%20patients%20with%20advanced%20soft%20tissue%20sarcoma%20%28STS%29%20supported%20accelerated%20FDA%20approval%20of%20this%20regimen.%20Radiation%20therapy%20%28RT%29%20is%20frequently%20used%20for%20high-risk%20localized%20STS.%20However%2C%20olaratumab%20has%20not%20been%20tested%20with%20concurrent%20RT.%20Here%2C%20we%20evaluate%20the%20chimeric%20anti-mouse%20PDGFR%5Cu03b1%20antibody%201E10Fc%20as%20a%20radiosensitizer%20in%20a%20primary%20mouse%20model%20of%20STS.%5CnMETHODS%3A%20Primary%20STS%20were%20initiated%20in%20mice.%20When%20tumors%20reached%2070%5Cu202fmm3%2C%20mice%20were%20allocated%20into%20treatment%20groups%3A%201%29%20isotype%2C%202%29%201E10Fc%2C%203%29%20isotype%20%2B%20RT%2C%204%29%201E10Fc%5Cu202f%2B%5Cu202fRT.%201E10Fc%20or%20isotype%20was%20given%20biweekly.%20RT%20%2825%5Cu202fGy%20delivered%20in%205%20daily%205%5Cu202fGy%20fractions%29%20was%20initiated%20on%20Day%200%20with%20first%20drug%20treatment.%20Tumors%20were%20measured%203%5Cu00d7%20per%20week.%20Upon%20reaching%20900%5Cu202fmm3%2C%20tumors%20and%20lungs%20were%20harvested.%20A%20two-way%20ANOVA%20was%20performed%20to%20compare%20tumor%20growth%20delay.%20Primary%20tumors%20were%20stained%20for%20CD31%20and%20PDGFR%5Cu03b1%20and%20lungs%20were%20assessed%20for%20micrometastases.%20A%20Chi-square%20test%20was%20performed%20to%20compare%20the%20development%20of%20micrometastases%20in%20the%20lungs%20after%20treatment%20with%201E10Fc%20or%20isotype.%5CnFINDINGS%3A%20RT%20significantly%20delayed%20time%20to%20tumor%20quintupling%20compared%20to%20no%20RT%20%28p%5Cu202f%3C%5Cu202f0%5Cu00b70001%29%20%5Btwo-way%20ANOVA%5D%2C%20but%20no%20difference%20in%20tumor%20growth%20was%20seen%20between%20mice%20receiving%20isotype%20or%201E10Fc%20treatment%20regardless%20of%20concurrent%20RT.%20Lower%20microvessel%20density%20was%20observed%20in%20the%201E10Fc%5Cu202f%2B%5Cu202fRT%20group.%20Fewer%20mice%20treated%20with%201E10Fc%20had%20micrometastases%2C%20but%20this%20difference%20was%20not%20statistically%20significant%20%28p%5Cu202f%3C%5Cu202f0%5Cu00b709%29.%5CnINTERPRETATION%3A%201E10Fc%20did%20not%20act%20as%20a%20radiosensitizer%20in%20this%20primary%20STS%20model.%5CnFUNDING%3A%20This%20study%20was%20funded%20by%20a%20research%20agreement%20from%20Eli%20Lilly%20and%20Company.%22%2C%22date%22%3A%22Feb%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ebiom.2019.01.046%22%2C%22ISSN%22%3A%222352-3964%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22LBJCS3N3%22%5D%2C%22dateModified%22%3A%222019-05-13T16%3A01%3A14Z%22%7D%7D%2C%7B%22key%22%3A%22KNMCEM25%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fontanella%20et%20al.%22%2C%22parsedDate%22%3A%222013-11%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EFontanella%2C%20A.%20N.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20Quantitative%20Mapping%20of%20Hemodynamics%20in%20the%20Lung%2C%20Brain%2C%20and%20Dorsal%20Window%20Chamber-Grown%20Tumors%20Using%20a%20Novel%2C%20Automated%20Algorithm.%20%3Ci%3EMicrocirculation%3C%5C%2Fi%3E%20%3Cb%3E20%3C%5C%2Fb%3E%2C%20724%26%23x2013%3B735%20%282013%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Quantitative%20Mapping%20of%20Hemodynamics%20in%20the%20Lung%2C%20Brain%2C%20and%20Dorsal%20Window%20Chamber-Grown%20Tumors%20Using%20a%20Novel%2C%20Automated%20Algorithm%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20N.%22%2C%22lastName%22%3A%22Fontanella%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thies%22%2C%22lastName%22%3A%22Schroeder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daryl%20W.%22%2C%22lastName%22%3A%22Hochman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raymond%20E.%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabi%22%2C%22lastName%22%3A%22Hanna%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20M.%22%2C%22lastName%22%3A%22Haglund%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20W.%22%2C%22lastName%22%3A%22Secomb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%20M.%22%2C%22lastName%22%3A%22Palmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20W.%22%2C%22lastName%22%3A%22Dewhirst%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Nov%202013%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1111%5C%2Fmicc.12072%22%2C%22ISSN%22%3A%221073-9688%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22MVSXFHG3%22%2C%226DAMZTTH%22%5D%2C%22dateModified%22%3A%222019-05-09T13%3A38%3A57Z%22%7D%7D%2C%7B%22key%22%3A%22G6UGC7D8%22%2C%22library%22%3A%7B%22id%22%3A1834780%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zhang%20et%20al.%22%2C%22parsedDate%22%3A%222009-08-16%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EZhang%2C%20G.%20%3Ci%3Eet%20al.%3C%5C%2Fi%3E%20POLY%20216-Boron%20biomaterials%20for%20imaging%20and%20oxygen%20sensing.%20%3Ci%3EAbstracts%20of%20Papers%20of%20the%20American%20Chemical%20Society%3C%5C%2Fi%3E%20%3Cb%3E238%3C%5C%2Fb%3E%2C%20%282009%29.%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22POLY%20216-Boron%20biomaterials%20for%20imaging%20and%20oxygen%20sensing%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guoqing%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cassandra%20L.%22%2C%22lastName%22%3A%22Fraser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Hamm-Alvarez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jiansong%22%2C%22lastName%22%3A%22Xie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20J.%22%2C%22lastName%22%3A%22Price%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%20M.%22%2C%22lastName%22%3A%22Palmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20W.%22%2C%22lastName%22%3A%22Dewhirst%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Aug%2016%202009%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%220065-7727%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22MVSXFHG3%22%5D%2C%22dateModified%22%3A%222019-05-09T13%3A38%3A21Z%22%7D%7D%5D%7D
1.
Banks, P. A. et al. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut 62, 102–111 (2013).
1.
Malecki, E. A., Castellanos, K. J., Cabay, R. J. & Fantuzzi, G. Therapeutic administration of orlistat, rosiglitazone or the chemokine receptor antagonist RS102895 fails to improve the severity of acute pancreatitis in obese mice. Pancreas 43, 903–908 (2014).
1.
Lilja, H. E., Leppäniemi, A. & Kemppainen, E. Utilization of intensive care unit resources in severe acute pancreatitis. JOP 9, 179–184 (2008).
1.
Buter, A., Imrie, C. W., Carter, C. R., Evans, S. & McKay, C. J. Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis. Br J Surg 89, 298–302 (2002).
1.
Mofidi, R. et al. Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis. Br J Surg 93, 738–744 (2006).
1.
Singh, H. et al. Which Patients with Mild Acute Pancreatitis Require Prolonged Hospitalization? Clin Transl Gastroenterol 8, e129 (2017).
1.
Kroner, P. T., Jirapinyo, P., Abougergi, M. S. & Thompson, C. C. Acute Pancreatitis Regional and Divisional Cost Variations Throughout the United States: A 10-Year Nationwide analysis. Gastroenterology 152, S445 (2017).
1.
Andersson, B. et al. Acute pancreatitis – costs for healthcare and loss of production. Scandinavian Journal of Gastroenterology 48, 1459–1465 (2013).
1.
Rashid, N., Sharma, P., Scott, R. & Toth, P. Evaluation of Healthcare Care Utilization and Costs Related to Acute Pancreatitis for Patients with Very Severe Hypertriglyceridemia. Journal of Clinical Lipidology 9, 431–432 (2015).
1.
Beenen, E., Brown, L. & Connor, S. A comparison of the hospital costs of open vs. minimally invasive surgical management of necrotizing pancreatitis. HPB 13, 178–184 (2011).
1.
Yeh, J. L., Wu, S. & Wu, B. U. Regional cost variation for acute pancreatitis in the U.S. JOP 15, 448–454 (2014).
1.
Pieńkowska, J. et al. Perfusion-CT - Can We Predict Acute Pancreatitis Outcome within the First 24 Hours from the Onset of Symptoms? PLoS One 11, (2016).
1.
Tsuji, Y., Takahashi, N. & Tsutomu, C. Pancreatic Perfusion CT in Early Stage of Severe Acute Pancreatitis. Int J Inflam 2012, (2012).
1.
Munigala, S. et al. Predictors for early readmission in acute pancreatitis (AP) in the United States (US) - A nationwide population based study. Pancreatology 17, 534–542 (2017).
1.
Green, R., Charman, S. C. & Palser, T. Early definitive treatment rate as a quality indicator of care in acute gallstone pancreatitis. Br J Surg 104, 1686–1694 (2017).
1.
Yadav, A. K. et al. Perfusion CT: can it predict the development of pancreatic necrosis in early stage of severe acute pancreatitis? Abdom Imaging 40, 488–499 (2015).
1.
Tsuji, Y. et al. Perfusion computerized tomography can predict pancreatic necrosis in early stages of severe acute pancreatitis. Clin. Gastroenterol. Hepatol. 5, 1484–1492 (2007).
1.
Hussain, N., Wu, F., Zhu, L., Thrall, R. S. & Kresch, M. J. Neutrophil apoptosis during the development and resolution of oleic acid-induced acute lung injury in the rat. Am. J. Respir. Cell Mol. Biol. 19, 867–874 (1998).
1.
Domschke, S., Malfertheiner, P., Uhl, W., Büchler, M. & Domschke, W. Free fatty acids in serum of patients with acute necrotizing or edematous pancreatitis. Int. J. Pancreatol. 13, 105–110 (1993).
1.
Sztefko, K. & Panek, J. Serum free fatty acid concentration in patients with acute pancreatitis. Pancreatology 1, 230–236 (2001).
1.
Nordback, I. & Lauslahti, K. Clinical pathology of acute necrotising pancreatitis. J. Clin. Pathol. 39, 68–74 (1986).
1.
Balthazar, E. J., Robinson, D. L., Megibow, A. J. & Ranson, J. H. Acute pancreatitis: value of CT in establishing prognosis. Radiology 174, 331–336 (1990).
1.
Yoon, S. B. et al. Impact of body fat and muscle distribution on severity of acute pancreatitis. Pancreatology 17, 188–193 (2017).
1.
Yashima, Y. et al. A large volume of visceral adipose tissue leads to severe acute pancreatitis. J. Gastroenterol. 46, 1213–1218 (2011).
1.
Donigan, M. et al. A metastatic colon cancer model using nonoperative transanal rectal injection. Surg Endosc 24, 642–647 (2010).
1.
Turker, N. S., Heidari, P., Kucherlapati, R., Kucherlapati, M. & Mahmood, U. An EGFR Targeted PET Imaging Probe for the Detection of Colonic Adenocarcinomas in the Setting of Colitis. Theranostics 4, 893–903 (2014).
1.
Zhao, X., Li, L., Starr, T. K. & Subramanian, S. Tumor location impacts immune response in mouse models of colon cancer. Oncotarget 8, 54775–54787 (2017).
1.
Forsmark, C. E. et al. Accelerating the Drug Delivery Pipeline for Acute and Chronic Pancreatitis: Summary of the Working Group on Drug Development and Trials in Chronic Pancreatitis at the National Institute of Diabetes and Digestive and Kidney Diseases Workshop. Pancreas 47, 1200–1207 (2018).
1.
Abu-El-Haija, M. et al. Accelerating the Drug Delivery Pipeline for Acute and Chronic Pancreatitis: Summary of the Working Group on Drug Development and Trials in Acute Pancreatitis at the National Institute of Diabetes and Digestive and Kidney Diseases Workshop. Pancreas 47, 1185–1192 (2018).
1.
Uc, A. et al. Accelerating the Drug Delivery Pipeline for Acute and Chronic Pancreatitis-Knowledge Gaps and Research Opportunities: Overview Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop. Pancreas 47, 1180–1184 (2018).
1.
Sennello, J. A. et al. Interleukin-18, together with interleukin-12, induces severe acute pancreatitis in obese but not in nonobese leptin-deficient mice. Proc Natl Acad Sci U S A 105, 8085–8090 (2008).
1.
Anandan, S.-K., GREENMAN, K., KAMAL, Z. & Singh, V. P. Compounds for the reducing lipotoxic damage. (2019).
1.
Ismail, O. Z. & Bhayana, V. Lipase or amylase for the diagnosis of acute pancreatitis? Clin. Biochem. 50, 1275–1280 (2017).
1.
Thiruvengadam, N. R. et al. Rectal Indomethacin Reduces Pancreatitis in High- and Low-Risk Patients Undergoing Endoscopic Retrograde Cholangiopancreatography. Gastroenterology 151, 288-297.e4 (2016).
1.
Song, A. M. et al. Inhibition of cyclooxygenase-2 ameliorates the severity of pancreatitis and associated lung injury. American Journal of Physiology-Gastrointestinal and Liver Physiology 283, G1166–G1174 (2002).
1.
Patel, K. et al. Lipolysis of Visceral Adipocyte Triglyceride by Pancreatic Lipases Converts Mild Acute Pancreatitis to Severe Pancreatitis Independent of Necrosis and Inflammation. The American Journal of Pathology 185, 808–819 (2015).
1.
Nawaz, H. et al. Elevated Serum Triglycerides are Independently Associated With Persistent Organ Failure in Acute Pancreatitis. American Journal of Gastroenterology 110, 1497 (2015).
1.
Matthay, M. A. & Zemans, R. L. The Acute Respiratory Distress Syndrome: Pathogenesis and Treatment. Annu. Rev. Pathol. Mech. Dis. 6, 147–163 (2011).
1.
Habtezion, A., Gukovskaya, A. S. & Pandol, S. J. Acute Pancreatitis: A Multifaceted Set of Organelle and Cellular Interactions. Gastroenterology 156, 1941–1950 (2019).
1.
Durgampudi, C. et al. Acute Lipotoxicity Regulates Severity of Biliary Acute Pancreatitis without Affecting Its Initiation. The American Journal of Pathology 184, 1773–1784 (2014).
1.
Garg, P. K. & Singh, V. P. Organ Failure Due to Systemic Injury in Acute Pancreatitis. Gastroenterology 156, 2008–2023 (2019).
1.
Xiao, A. Y. et al. Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies. Lancet Gastroenterol Hepatol 1, 45–55 (2016).
1.
Yadav, D. & Lowenfels, A. B. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 144, 1252–1261 (2013).
1.
Peery, A. F. et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology 143, 1179-1187.e3 (2012).
1.
Lasher, D. et al. Protease-Sensitive Pancreatic Lipase Variants Are Associated With Early Onset Chronic Pancreatitis. Am. J. Gastroenterol. 114, 974–983 (2019).
1.
Navina, S. et al. Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity. Sci Transl Med 3, 107ra110 (2011).
1.
Noel, P. et al. Peripancreatic fat necrosis worsens acute pancreatitis independent of pancreatic necrosis via unsaturated fatty acids increased in human pancreatic necrosis collections. Gut 65, 100–111 (2016).
1.
Song, E. J. et al. Investigating a chimeric anti-mouse PDGFRα antibody as a radiosensitizer in primary mouse sarcomas. EBioMedicine 40, 224–230 (2019).
1.
Fontanella, A. N. et al. Quantitative Mapping of Hemodynamics in the Lung, Brain, and Dorsal Window Chamber-Grown Tumors Using a Novel, Automated Algorithm. Microcirculation 20, 724–735 (2013).
1.
Zhang, G. et al. POLY 216-Boron biomaterials for imaging and oxygen sensing. Abstracts of Papers of the American Chemical Society 238, (2009).